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Occupational exposures to vancomycin-resistant Enterococcus (VRE) and 
methicillin-resistant Staphylococcus aureus (MRSA) in reclaimed wastewater used for 
spray irrigation were evaluated. In 2009, wastewater was collected from a tertiary-
treatment facility, and reclaimed wastewater, nasal and dermal swab samples from an 
irrigation site. Samples were evaluated for MRSA and VRE using standard methods, 
PCR, and susceptibility testing. MRSA and VRE were isolated from all wastewater 
samples except effluent. While wastewater MRSA isolates were multidrug resistant 
(98%), no MRSA was isolated in irrigation water or swabs. VRE was isolated in one 
irrigation water sample. Fewer irrigation workers were colonized with S. aureus (31%) 
compared to controls (46%), but they harbored more multidrug resistant S. aureus. This is 
the first study to 1) evaluate antibiotic-resistant bacteria (ARB) in U.S. reclaimed 
  
wastewater and resulting occupational exposures, and 2) detect MRSA in U.S. 
wastewater. The findings suggested that tertiary wastewater treatment effectively reduced 
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Chapter 1: Introduction 
 
Water Use 
Water is an essential component of the human body, a necessity for good health 
and agriculture, and if contaminated, a carrier of harmful xenobiotics. At the beginning of 
the twenty-first century, 70 percent of all water used from surface and ground water 
around the world was being used for agriculture (FAO, 2003; Kocaman, Yaganoglu, & 
Angin, 2007). The Food and Agriculture Organization of the United Nations anticipates 
that agricultural water use will increase by another 14 percent between 2000 and 2030 
(FAO, 2003; Kocaman, et al., 2007). Consumption of water for drinking, industrial, and 
household uses has increased as well, globally and in the United States (Angin, 
Yaganoglu, & Turan, 2005; Dobbie, Henderson, & Stevens Jr., 2008; EPA, 2008b; 
Kocaman, et al., 2007; Levine & Asano, 2004; Rodriguez, et al., 2009; UN, 2003).  
In the United States in 2005, approximately 410 billion gallons of water were 
withdrawn per day for use (Barber, 2009). Demand for public and domestic water uses 
has increased steadily since 1950 in the U.S. (Barber, 2009). Although national demand 
for water is increasing, the water supply is not, and it is in fact decreasing. According to 
the Government Accountability Office, 36 states are expected to experience water 
shortages by 2013, even in “normal, non-drought conditions” (GAO, 2003). As water use 
increases, and droughts and water shortages become more common, agricultural and 
landscaping applications across the United States increasingly use reclaimed wastewater 




2004). One of the first documented uses of reclaimed wastewater in the United States was 
Golden Gate Park in San Francisco, California in 1912 when reclaimed wastewater was 
used for lawn irrigation and to replenish ornamental lakes (Asano, 2001). Since this use, 
the number and type of applications of reclaimed wastewater in the United States have 
continued to grow. 
Although there are many potential benefits from using reclaimed wastewater, 
including reduced cost and freshwater conservation, the potential public health 
implications of its use have not been fully explored. Previous studies have analyzed 
specific microbial and chemical contaminants in wastewater and treated wastewater, but 
no studies to date have quantified the prevalence of antibiotic-resistant bacteria in 
reclaimed wastewater used for spray irrigation in the United States or the public health 
implications of occupational exposure to this media (Borjesson, Melin, Matussek, & 
Lindgren; Börjesson, Melin, Matussek, & Lindgren, 2009; Caplin, Hanlon, & Taylor, 
2008; de Zutter & van Hoof, 1984; Harwood, Brownell, Perusek, & Whitlock, 2001; 
Iwane, Urase, & Yamamoto, 2001; Miguel Ferreira da Silva, et al., 2006; Mispagel & 
Gray, 2005; Poole, et al., 2005; Rose, 2007; Schwartz, Kohnen, Jansen, & Obst, 2003; 
Volkmann, Schwartz, Bischoff, Kirchen, & Obst, 2004). This thesis seeks to contribute to 
the current limited body of knowledge on possible health risks, or lack thereof, from 
exposure to reclaimed wastewater. To be as cautious as possible, before continuing to 
expose the public to new sources of irrigation and drinking water, it is most prudent to 





Microbial Contaminants in Wastewater 
Bacterial pathogens occur in large quantities in wastewater because they are 
excreted in the feces of colonized individuals. In addition to large concentrations of 
bacterial pathogens as a whole, wastewater also contains antibiotic-resistant bacteria 
(Garcia, et al., 2007; Nagulapally, et al., 2009). Antibiotic-resistant bacteria are bacteria 
that have acquired resistance, or are inherently resistant, to antimicrobials that would 
otherwise limit their growth or kill them. Antibiotic-resistant bacteria present a threat to 
human health because they limit treatment options, often cause more serious infections 
than their antibiotic-susceptible counterparts, and are more likely to cause mortality 
(Drees, et al., 2008; Siegel, Rhinehart, Jackson, Chiarello, & Committee, 2006; Zhang, 
Marrs, Simon, & Xi, 2009). The concentration of antibiotics released into wastewater are 
often high enough to exert selective pressures to favor the proliferation of resistant strains 
of microorganisms (Garcia, et al., 2007; Kummerer, 2001). The combination of high 
concentrations of microorganisms, nutrients, and antibiotics found in wastewater makes it 
a favorable environment for bacterial growth and horizontal transfer of resistance genes 
(Garcia, et al., 2007; Lorenz & Wackemagel, 1994; Mezrioui & Baleux, 1994; 
Nagulapally, et al., 2009). 
Methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant 
Enterococcus spp. (VRE) are two of the leading causes of antibiotic-resistant bacterial 
infections in hospital settings, and rising causes of community-acquired infections 
(Siegel, et al., 2006; Sievert, et al., 2008; System, 2004). Because of their increasing 
occurrence in human infections and high rates of related mortality, MRSA and VRE are 




To my knowledge, only one study has previously identified MRSA in wastewater 
in Europe and no studies have identified MRSA from wastewater or reclaimed 
wastewater in the United States (Börjesson, et al., 2009). VRE has been identified in 
wastewater in the United States in a limited number of studies, but has never been 
examined in treated wastewater used in downstream applications (Beier, et al., 2008; 
Garcia, et al., 2007; Harwood, et al., 2001; Nagulapally, et al., 2009; Poole, et al., 2005). 
Public Health Risks 
If bacterial pathogens and antibiotic-resistant bacteria survive the wastewater 
treatment process, there is the possibility for occupational exposure to these agents 
among wastewater treatment plant workers and employees engaged in the use of 
reclaimed wastewater (Nagulapally, et al., 2009). Spray irrigators using reclaimed 
wastewater have higher levels of exposure to reclaimed wastewater than the general 
public and could potentially be exposed to contaminants contained in the water, including 
antibiotic-resistant bacteria. The public health consequences of exposure to reclaimed 
wastewater, and specifically occupational exposure to reclaimed wastewater, have not 
been fully evaluated. 
More research on the possible health risks of exposure to reclaimed wastewater is 
needed. In a world with increasing droughts and demands on water resources, even with 
improvements in water efficiency and conservation, we will most likely begin to rely 
more heavily on alternative water sources. To protect human health, additional research is 





The overall goal of the research conducted in the current Master’s thesis project 
was to generate baseline information about the presence of antibiotic-resistant bacteria in 
wastewater and reclaimed wastewater and the accompanying public health risks from 
occupational exposure to treated wastewater. My Master’s thesis evaluated potential 
occupational exposures to antibiotic-resistant bacteria in reclaimed wastewater among 
spray irrigation workers. My central hypothesis was that untreated municipal wastewater, 
and treated municipal wastewater used in spray irrigation activities would contain 
pathogenic, and antibiotic-resistant, bacteria. As a consequence, spray irrigation workers 
using reclaimed wastewater for irrigation would be exposed to these agents through both 
inhalation and dermal routes of exposure.  
The specific aims of the study were as follows: 
1. To determine the presence of methicillin-resistant Staphylococcus aureus 
(MRSA) and vancomycin-resistant Enterococcus spp. (VRE) at a tertiary 
municipal wastewater treatment plant. 
2. To evaluate air and reclaimed wastewater samples collected during reclaimed 
wastewater irrigation activities for the presence of MRSA and VRE. 
3. To determine exposure levels and exposure routes of MRSA and VRE among 
spray irrigation workers from nasal and dermal swab samples. 
The findings contained in this Master’s thesis will serve as the foundation for 
future epidemiological studies to comprehensively evaluate the public health risks 








As the use of reclaimed wastewater continues and expands in applications in 
which occupational and general public exposures could occur, it would be helpful to have 
a holistic picture of human health risks from exposures to this alternative source of water. 
In particular, this Master’s thesis focuses on possible occupational exposures to 
methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant 
Enterococcus spp. (VRE) from reclaimed wastewater used in spray irrigation. This 
chapter provides background on MRSA, VRE, wastewater treatment in the United States, 




Staphylococci are one of the most common bacterial pathogens that cause disease 
in humans (Metzger, Bonotti, & Sawyer, 2009). Out of 32 species and 15 subspecies of 
Staphylococcus, S. aureus is one of the species most commonly associated with human 





S. aureus are round, often cluster in chain or grape-shaped formation, and are 
usually golden colored because of carotenoid pigments produced during the growth phase 
(Murray, et al., 2002). The name “aureus”, the Latin word for golden, refers to the golden 
color of the organisms. These organisms are aerobic or facultatively anaerobic, which 
means that they are able to grow in both aerobic and anaerobic conditions (Murray, et al., 
2002). S. aureus can also grow in environments with salt concentrations as high as 10% 
(Friis, 2007). The optimal temperature range for S. aureus is between 18 and 40°C, which 
spans the average internal temperature of the human body. 
S. aureus are generally larger than 5 µm in aerodynamic diameter and thus more 
likely to settle quickly (Andersen, 1958; Bassetti, et al., 2005; Jensen, Todd, Davis, & 
Scarpino, 1992). This partially explains why S. aureus are often found in the nares of 
humans and animals, and not deeper in the respiratory system.  
Several of S. aureus’ physical properties help it to survive in a range of 
environments. S. aureus is a gram-positive bacterium, which means that it has a 
peptidogylycan layer that helps it exist in harsh environments. The peptidoglycan layer is 
a thick, rigid component of the cell wall and can stimulate immune responses in the body 
(Murray, et al., 2002). 
S. aureus is catalase-positive, which means it can catalyze the breakdown of 
hydrogen peroxide into water and oxygen. Hydrogen peroxide can accumulate during 
bacterial metabolism and is toxic to the cell (Murray, et al., 2002). A polysaccharide, or 
slime, layer is thought to occur frequently in S. aureus that protects it from injury and 




serotypes of S. aureus that have a polysaccaride capsule (Murray, et al., 2002). This 
physical characteristic could be important for the survival of S. aureus in the environment 
and the human body. S. aureus are also resistant to drying, are carried by airborne 
particles, and are frequent colonizers of the nasal mucosa (Lidwell, Brock, Shooter, 
Cooke, & Thomas, 1975). 
In addition to possessing characteristics that help it survive in the environment, S. 
aureus can also elicit immune responses in the body. Protein A, located on the surface of 
most strains of S. aureus, selectively binds to the receptors for immunoglobulin, which 
produce antibodies. Protein A inhibits the production of antibodies and therefore the 
clearance of S. aureus from the body (Murray, et al., 2002). Once inside the body, S. 
aureus is able to survive partially due to bound coagulase, a clumping factor that helps 
the organism bind to tissue surfaces. S. aureus is the only species of Staphylococcus to 
produce this enzyme (Murray, et al., 2002). Some strains of S. aureus also produce a 
highly heat-stable protein toxin, or enterotoxin (FDA, 2009). 
Ecological Habitat and Distribution 
Staphylococci are found throughout the environment in humans and animals, air, 
dust, water, milk, and food, although humans and animals are the primary reservoirs 
(FDA, 2009). This bacterium can be found on the skin and mucous membranes of a large 
percentage of healthy humans and animals (Center for Disease Control and Prevention 
(CDC), 2006). 
Humans 
It has been estimated that S. aureus is present in the nose, throats, hair, and skin of 




healthcare workers, hospital patients, and regular needle users are colonized with this 
bacterium (Murray, et al., 2002). Colonization with S. aureus can be either acute or 
chronic (Chambers, 2001; Sanford, Widmer, Bale, Jones, & Wenzel, 1994). Colonization 
with S. aureus is not homogeneous across subpopulations, but rather differs by gender, 
ethnicity, age, and other demographic factors. Based on National Health and Nutrition 
Examination Survey (NHANES) data, males, compared with females (P < .001), non-
Hispanic whites and Mexican Americans, compared with non-Hispanic blacks (P < .001 
and P < .01, respectively), obese individuals (P < .01, men; P < .05, women), and 
individuals less than 20 years old, compared with older persons (P < .001) were more 
likely to be colonized with S. aureus (Gorwitz, et al., 2008). One reason why children 
have higher colonization rates than adults, could be because of their frequent contact with 
respiratory secretions (Chambers, 2001; Ross, Rodroguez, Controni, & Khan, 1974). In 
neonates, S. aureus is often found in the oropharynx, umbilical stump, skin, and perineal 
area (Adcock, Pastor, Medley, Patterson, & Murphy, 1998). In adults, S. aureus is often 
found in moist skin folds, in the nasopharynx, gastrointestinal, and urogenital tract 
(Murray, et al., 2002). Although colonization is widespread among humans, the vast 
majority of individuals are asymptomatic rather than presenting for infection (Chambers, 
2001).  
An important subcategory of human sources of S. aureus is hospitals. Close inter-
individual contact, contaminated surfaces, and bodily fluids, make the hospital an ideal 





S. aureus can also be found in the nares, skin, genital, and gastrointestinal tracts 
of some warm-blooded animals (Rusin, Maxwell, Brooks, Gerba, & Pepper, 2003). 
Studies on the prevalence of S. aureus in animals are limited, but several studies have 
pointed to transmission of specific strains of S. aureus between animals and humans. A 
study conducted in Denmark found that 13 of 21 S. aureus infections in farm workers 
were among individuals who had been exposed to pigs with a similar strain of S. aureus 
(H. C. Lewis, et al., 2008). Additional studies conducted in France, the Netherlands, 
Canada, and the United States have also found evidence of transmission of S. aureus 
between humans and animals (D. Currie, 2008; H. C. Lewis, et al., 2008; Smith, et al., 
2009). 
Epidemiology and Pathogenicity 
S. aureus is associated with a wide range of infections. As of 2005, S. aureus was 
the most frequently identified cause of hospital-acquired infections in the United States, 
responsible for 20% of surgical-site infections, 18% of pneumonias, and 13% of 
bloodstream infections (Bassetti, et al., 2005; Program, Diseases, Prevention, Service, & 
Services., 1999). S. aureus is also commonly found in the general human population. 
According to samples collected in the 2003–2004 NHANES, between 27.2% and 30% of 
the United States population, or 75 to 82.9 million individuals, were colonized with S. 
aureus (Gorwitz, et al., 2008). Twenty to 30% of the general population have nasal 
colonization of S. aureus (Bassetti, et al., 2005; John & Barg, 1999). S. aureus has been 




incidence of antibiotic-resistant strains that cause infections that cannot be treated with 
common antibiotics.  
Methicillin Resistance 
 MRSA is a type of S. aureus that possesses genes that confer resistance to 
penicillinase-stable penicillins, which include methicillin, oxacillin, penicillin, and 
ampicillin. mecA is the most common gene that encodes resistance to methicillin among 
MRSA isolates (Araj, Talhouk, Simaan, & Maasad, 1999). The first strains of MRSA 
were observed in the early 1960s (Ornskov, et al., 2007). MRSA infections have 
historically occurred predominantly in hospitals and healthcare facilities among 
individuals with weakened immune systems and other risk factors, such as foreign 
objects in the body (CDC, 2009). MRSA infections are now being identified in otherwise 
healthy individuals outside of the healthcare setting. This type of infection is called a 
community-associated (or community-acquired) (CA-MRSA) infection. Both nosocomial 
and CA-MRSA infections are often associated with skin and soft tissue infections (SSTI) 
(CDC, 2009).  
 Using data from the 2001-2002 and 2003-2004 NHANES of the U.S. population, 
the prevalence of methicillin-susceptible S. aureus (MSSA) colonization in the anterior 
nares decreased, while the prevalence of MRSA colonization increased (Gorwitz, et al., 
2008). Between 1997 and 1999 the number of both nosocomial and CA-MRSA infections 
increased (Diekema, et al., 2001). In 2005, MRSA infections were ultimately responsible 





 Nosocomial and CA-MRSA isolated in the United States through the SENTRY 
Antimicrobial Surveillance Program exhibited resistance to a median of three 
antimicrobial classes in addition to methicillin (Diekema, et al., 2001). Nearly 15% of 
MRSA isolates were also resistant to tetracycline (Diekema, et al., 2001). The Asia-
Pacific region, including Taiwan, Singapore, Japan, and Hong Kong had the highest rates 
of methicillin resistance (greater than 60%) among S. aureus isolates identified through 
the SENTRY program (Diekema, et al., 2001).  
 Hospital acquired MRSA 
 By the end of 1998, the prevalence of MRSA isolates from intensive care units was 
almost 50% (Chambers, 2001). Most nosocomial strains of MRSA are resistant to several 
classes of antimicrobials including aminoglycosides, erythromycin, clindamycin, and 
tetracycline (Flynn & Cohen, 2008).  
 Community associated MRSA 
The emergence of CA-MRSA is associated with infections among individuals 
who lack traditional risk factors, such as direct contact with healthcare workers, 
hospitalization, and previous antimicrobial treatment (Chambers, 2001). CA-MRSA 
spreads through skin-to-skin contact and is associated with SSTIs as well as severe 
systemic infections such as sepsis and necrotizing pneumonia (Malik, Vranken, Silio, 
Ratard, & Van Dyke, 2006; Ozaki, et al., 2009). CA-MRSA often exhibits multiple 
resistance to erythromycin (98%) and β-lactam agents (ampicillin, 99%; penicillin, 99%) 
(Bou, 2007). Most community-associated strains of MRSA are susceptible primarily to 
clindamycin and tetracyclines (Flynn & Cohen, 2008). Although genetic differences exist 




increasingly found in both community and healthcare settings, challenging the relevance 
of separating the two types of infections (Gorwitz, et al., 2008; Healy, Hulten, Palazzi, 
Campbell, & Baker, 2004; Kourbatova, et al., 2005; Miller & Diep, 2008; Saiman, 




Previously classified as group D streptococci, enterococci are gram-positive, 
catalase-negative, cocci able to grow in the presence of high levels of bile and sodium 
chloride (Fisher & Phillips, 2009; Murray, et al., 2002; Spacek & Vinetz, 2009). 
Enterococcus spp. are facultatively anaerobic and more resistant to chlorination and other 
environmental factors than other types of coliforms (Fisher & Phillips, 2009; Maier, 
2009). The temperature range for enterococci is between 5 and 50°C which encompasses 
the average human body temperature, 37°C (Fisher & Phillips, 2009). It is important to 
note that optimal temperature for enterococci is 35°C (Murray, et al., 2002). 
Ecological habitat and distribution 
Enterococci are part of the common flora of the human intestines and the female 
genital tract (Centers for Disease Control and Prevention (CDC), 2008; Murray, et al., 
2002; Spacek & Vinetz, 2009). Because they are found in the animal and human gut, 
Enterococcus spp. are often used as indicators of fecal contamination ((Centers for 
Disease Control and Prevention (CDC), 2008)). Small numbers of E. faecalis and E. 




Enterococcus spp. can also be found in the environment in soil, water, and food (Spacek 
& Vinetz, 2009). 
Epidemiology and Pathogenicity 
Enterococci are commensal organisms that were historically classified as 
opportunistic pathogens. As such, they can cause urinary tract infections as well as 
infections of the bloodstream (bacteremia) and wounds, meningitis, and endocarditis 
(Centers for Disease Control and Prevention (CDC), 2008; Murray, et al., 2002; Spacek 
& Vinetz, 2009). Between 2006 and 2007, one out of every eight hospital infections was 
caused by Enterococcus spp. (Centers for Disease Control and Prevention (CDC), 2008). 
Approximately 30% of these infections were resistant to the antibiotic vancomycin 
(Centers for Disease Control and Prevention (CDC), 2008).  
Vancomycin Resistance 
The first cases of enterococci with high levels of resistance to vancomycin were 
reported in the United Kingdom in the 1980s (Uttley, Collins, Naidoo, & George, 1988; 
Zirakzadeh & Patel, 2006). Vancomycin is typically considered a “last resort” drug to 
treat gram-positive bacterial infections (Nagulapally, et al., 2009; Wegener, Aarestrup, 
Jensen, Hammerum, & Bager, 1999). As of 2003, nearly 30% of all enterococci isolated 
from intensive care unit patients in the United States were resistant to vancomycin 
(Drees, et al., 2008; System, 2004). Many species of enterococci are also resistant to a 
number of other antibiotics, often in conjunction with vancomycin-resistance (Murray, 
Rosenthal, & Pfaller, 2009). Almost all E. faecium are resistant to ampicillin and as of 
2009 the majority of clinical E. faecalis isolates were resistant to vancomycin (Murray, et 




large, transferable chromosomal element, causing resistance to these two antibiotics to 
occur often in the same organisms (Hanrahan, Hoyen, & Rice, 2000). 
To date, it has been confirmed that seven different genes (vanA-vanG) can confer 
vancomycin resistance to Enterococcus spp., but the three most prevalent genes are vanA, 
vanB, and vanC (Fisher & Phillips, 2009). Both vanA and vanB are acquired, but vanA 
confers resistance to vancomycin and teicoplanin, while vanB only confers resistance to 
vancomycin (Patel, Uhl, Kohner, Hopkins, & Cockerill, 1997). vanC is an intrinsic 
resistance gene that most commonly occurs in E. gallinarum, E. casseliflavus, and E. 
flavescens, but it has also been identified in E. faecalis and E. faecium (Fisher & Phillips, 
2009; Patel, et al., 1997). The resistance genes vanA and vanB are of particular concern in 
terms of horizontal gene transfer because they occur on plasmids and can be easily 
transferred to other gram-positive bacteria, including S. aureus (Fisher & Phillips, 2009; 
Garcia, et al., 2007; Giraffa, 2002; Patel, et al., 1997; Poole, et al., 2005; Sievert, et al., 
2008; Zirakzadeh & Patel, 2006).  
Co-colonization of patients with VRE and MRSA has been observed with 
increasing frequency (Warren, Nitin, Hill, Fraser, & Kollef, 2004; Zirakzadeh & Patel, 
2006). Resistance genes can also be transferred between environmental and clinical 
settings, such as from clinical strains released into wastewater to community strains 
contained in the wastewater (Guardabassi & Dalsgaard, 2004). VRE are able to survive in 
the environment for approximately one week (Zirakzadeh & Patel, 2006). VRE can also 
be transferred between animals and humans. Kuhn et al. found that horizontal transfer of 





In addition to transfer of vancomycin resistance between strains of enterococci, 
vancomycin resistance can also be transferred from enterococci to other types of bacteria, 
including S. aureus (Sievert, et al., 2008). The Michigan Department of Community 
Health reported the first clinical isolate of vancomycin-resistant S. aureus (VRSA) in 
2002 (Sievert, et al., 2008). By 2008, only seven clinical cases of VRSA had been 
confirmed in the United States, but the incidence of VRSA infections could continue to 
rise (Sievert, et al., 2008). 
When compared with other types of nosocomial bacterial infections, VRE was 
associated with increased mortality, length of hospital stay, admission to the intensive 
care unit, surgical procedures, and associated costs (Carmeli, Eliopoulos, Mozaffari, & 
Samore, 2002; Drees, et al., 2008; Siegel, et al., 2006). 
 
Wastewater Treatment in the United States 
Wastewater treatment in the United States can be categorized into three main 
steps, primary, secondary, and tertiary treatment (Figure 1) (Maier, 2009). Primary 
treatment consists of the physical removal of large objects from incoming wastewater. 
Primary treatment usually includes screening of large objects, grit removal, and 
sedimentation (EPA, 2004b; Maier, 2009). Secondary treatment entails the use of 
biological processes to remove suspended solids and microorganisms from water that has 
already undergone primary treatment (Maier, 2009). The most common type of 
secondary treatment in the United States is the activated sludge process, which introduces 
nitrifying microorganisms and high levels of oxygen into wastewater to break down 




wastewater is slowed down in secondary clarifiers to induce die-off in the introduced 
microbial population. The secondary clarifiers also allow for physical removal of 
remaining organic material. The secondary treatment processes can remove as much as 
90% of organic matter from wastewater (EPA, 2004b). Secondary treatment is the 
minimum level of treatment required by the United States government through the Clean 
Water Act (EPA, 2004b). Tertiary treatment is any treatment beyond secondary treatment 
(Maier, 2009). Free chlorine is the most common disinfectant used in the tertiary 
treatment process, but chloramines, ultraviolet light, and ozone are also used (EPA, 
2004a, 2004b). In addition to disinfection, filtration and other processes can be employed 
in tertiary treatment. 
Microorganisms that pose a threat to human health are not necessarily completely 
removed during wastewater treatment. The primary goal of wastewater treatment is not to 
fully eradicate harmful contaminants that could affect human health, but to remove and 
degrade organic matter (Maier, 2009). 
In 2009, more than 15,000 wastewater treatment plants in the United States 
treated approximately 150 billion liters of wastewater per day (Maier, 2009). Wastewater 
treatment facilities in the United States range from less than secondary to tertiary 
treatment facilities. In 2004, approximately 100 million individuals living in the United 
States were serviced by 9,261 secondary, or less than secondary, wastewater treatment 
facilities (EPA, 2004b, 2008a). Secondary treatment facilities comprise over half of the 
municipal wastewater treatment facilities in the United States (EPA, 2004b, 2008a). More 
than 30% of municipal wastewater treatment facilities go beyond secondary treatment 




Bacteria in wastewater 
Raw wastewater contains a mixture of many substances, including pathogenic and 
non-pathogenic microorganisms, and antimicrobials that could pose a risk to human 
health (Rose, 2007). Several previous studies have analyzed the bacterial content of 
wastewater and aerosols from wastewater at isolated locations (Caplin, et al., 2008; de 
Zutter & van Hoof, 1984; Fracchia, Pietronave, Rinaldi, & Giovanna Martinotti, 2006; 
Harwood, et al., 2001; Iwane, et al., 2001; Karra & Katsivela, 2007; Miguel Ferreira da 
Silva, et al., 2006; Mispagel & Gray, 2005; Poole, et al., 2005; Prazmo, et al., 2003; 
Schwartz, et al., 2003; Volkmann, et al., 2004). These studies, however, have not 
followed the path of wastewater from effluent to secondary use, i.e. as a source of 
irrigation water or source water for drinking water treatment plants in the United States. 
Many of the organisms found in wastewater are mesophilic bacteria whose 
optimal temperature range is between 25-40°C, which includes the average temperature 
of the human body. The human body is a favorable habitat for these bacteria and 
therefore they pose a threat to human health. Individuals working with untreated and 
reclaimed wastewater might be exposed to these microorganisms in the form of 
aerosolized particles through inhalation or through direct contact. To be able to prevent 
adverse health outcomes from exposures to microbial contaminants, it is necessary to 
determine first the types of agents and their corresponding concentrations found in the 
water sources of interest. A study at a Polish wastewater treatment plant identified 34 
species of bacteria and 14 species of fungi in influent wastewater (Prazmo, et al., 2003). 




fungal species had possible allergenic and/or immunogenic properties, which could affect 
individuals exposed to both untreated and treated wastewater (Prazmo, et al., 2003).  
To address the issue of contaminants in incoming wastewater, wastewater 
treatment plants are designed to reduce the amount of organic matter, but reduction of 
enteric microorganisms can vary greatly and wastewater effluent often still contains 
detectable levels of these organisms (Koivunen, Siitonen, & Heinonen-Tanski, 2003; 
Rose, 2007). It may even be the case that the number of pathogenic microorganisms and 
percentage of antibiotic-resistant microorganisms increase at certain stages during the 
wastewater treatment process (de Zutter & van Hoof, 1984; Emparanza-Knorr & 
Torrella, 1995; Kayser, Boll, & Muller, 1987; Koivunen, et al., 2003; LeChevallier, 
Cawthon, & Lee, 1988). Prazmo et al. found that the concentration of total 
microorganisms analyzed was two to three times greater at the initial and intermediate 
treatment phases compared to the final treatment phase (Prazmo, et al., 2003).  
Wastewater treatment plants use indicator organisms, such as total coliforms and 
E. coli, to determine whether treatment processes have reduced microorganisms to a level 
of acceptable risk for human health. However, the absence of indicator organisms in 
treated wastewater does not necessarily mean that all bacteria present in incoming 
wastewater have been killed (Levine & Asano, 2004). Providing measurements of 
indicator organisms alone, therefore, might not be representative of true human health 
risks from all contaminants in reclaimed wastewater. 
Antibiotic-Resistant Bacteria in Wastewater 
Along with total microbial concentration, the concentration of antibiotic-resistant 




concluded that the percentage of antibiotic-resistant bacteria increases with secondary 
treatment, but decreases with tertiary treatments such as ultraviolet radiation or 
chlorination (Nakamura & Shirota, 1990; Prazmo, et al., 2003; Rose, 2007).  
Tolba et al. found that MRSA can survive for as many as 14 days in aquatic 
environments, both saline and non-saline (2008). MRSA is better adapted to survive in 
seawater than river water because of its preference for higher salinity (Tolba, et al., 
2008). Wastewater typically has high levels of salt, which suggest it would be a favorable 
environment for MRSA (Axelrad & Feinerman, 2009; Levine & Asano, 2004). However, 
some strains of MRSA are inhibited by high salt concentrations in the range of 7.5% 
(Smyth, Kahlmeter, Olsson Liljequist, & Hoffman, 2001). It might be difficult to isolate 
active microorganisms from a large volume of water when taking grab samples, but this 
does not rule out the possibility that those organisms are present. MRSA might also not 
be culturable or express resistance, but still be able to survive the transmission from 
hospital or home to wastewater treatment plant and the treatment process. If MRSA does 
survive wastewater treatment, it could come into contact with other environments or 
individuals. It also should be taken into consideration that at wastewater treatment plants, 
contaminants and microorganisms are concentrated, thereby increasing the risk of 
infection.  
Börjesson et al. recently published the first study to report successfully isolating 
MRSA from wastewater (Börjesson, et al., 2009). Several types of antibiotic-resistant 
bacteria occur in higher numbers in wastewater than in the natural environment, but in 
general, S. aureus occurs at low levels in both surface water and wastewater (Börjesson, 




study had a hydraulic retention time of 8 hours and a solid retention time of 2 to 4 days in 
the activated sludge system (Börjesson, et al., 2009). Combining these retention times 
with the results from Tolba et al.’s study that MRSA can survive in river water up to 14 
days, a plausible explanation appears for how MRSA can survive the wastewater 
treatment process and represent a risk for infection for those who come into contact with 
treated water or work in wastewater treatment plants (Börjesson, et al., 2009; Tolba, et 
al., 2008). MRSA was more prevalent in early, compared to final, treatment steps, but 
this could be due more to reduction of biomass than to effective removal of the 
microorganisms. Börjesson et al. identified an increase in the mecA gene concentration at 
the trickling filter. The association between high concentrations of antibiotic-resistant 
bacteria and trickling filters could be due to biofilms located on the filters’ surfaces. The 
trickling filter is similar to the biological aerated filter and effluent filters at the tertiary 
treatment plant sampled in the current study. These similarities emphasize the importance 
of taking water, air, and swab samples from these locations (Börjesson, et al., 2009; 
Fracchia, et al., 2006; Schwartz, et al., 2003). 
Aerosolization of Pathogens at Wastewater Treatment Plants 
Although the current study focused on contaminants found in reclaimed 
wastewater, aerosols also present an important exposure pathway. Bacteria can become 
airborne when they attach to skin, lint, and dust and spread via air currents, possibly to be 
taken up into the respiratory system (Weese & Ji, 2007). The inhalation route of exposure 
is one of the main exposure routes for pathogenic microorganisms from spray irrigation 
operations using reclaimed wastewater (Xie, Hu, Guo, & Wu, 2009). Outbreaks of 




2007). S. aureus has been isolated from air samples at wastewater treatment plants and 
has been found in high concentrations among individuals living in proximity to areas 
fertilized with treated wastewater. These findings suggest that wastewater treatment 
processes might not be effective at removing S. aureus from wastewater (Börjesson, et 
al., 2009).  
Seasonal Variations 
Enteric infections, caused by viruses and bacteria, have been found to vary 
seasonally (Gabriel, et al., 2010; Grassly & Fraser, 2006; Jung, Yoon, Jang, & Jeon, 
2007; Maier, 2009). For example, enteric infections caused by Campylobacter jejuni 
consistently peak in summer (Gabriel, et al., 2010; Jore, et al.; Jung, et al., 2007; Maier, 
2009). These seasonal peaks could be the result of changes in the survival rate of 
different agents in the environment during different seasons and/or the seasonal exchange 
between groundwater and surface water (Harwood, et al., 2001; Maier, 2009). In addition 
to the impact of temperature on water levels and the exchange of water between different 
reservoirs, temperature has also been studied as a limiting factor for the survival of 
culturable Enterococcus spp. in freshwater (Scott, Jenkins, Lukasik, & Rose, 2005). In 
terms of antibiotic-resistant bacteria, low temperatures and low flow were found to 
increase resistance among Acinetobacter spp. to a greater number of antibiotics (Zhang, 
et al., 2009). High water temperatures might accelerate degradation of antibiotics and 
high flows could reduce the concentration of antibiotics in water and thereby reduce 
selective pressure for antibiotic resistance (Zhang, et al., 2009). 
Studies looking at aerosolized bacteria in wastewater treatment plants have noted 




attributed to meteorological conditions (Fracchia, et al., 2006; Karra & Katsivela, 2007). 
Karra and Katsivela found that solar radiation, temperature, and relative humidity, all 
factors that are correlated with seasonal changes, were the most important factors 
associated with the concentration of aerosolized microorganisms (Karra & Katsivela, 
2007).  
Reclaimed Wastewater Use in the United States 
Great potential exists for harnessing treated wastewater for reuse instead of 
discharging it into water bodies and withdrawing freshwater for use, which have been the 
historical patterns. Although publically-supplied water in the United States is treated to 
obtain potable levels, this level of treatment is not required for all uses, such as industrial 
and landscaping applications (EPA, 2004a). Reclaimed wastewater is already being used 
across the United States for a number of different activities. In 2004, 1.7 billion gallons 
of reclaimed wastewater were used per day in the United States (EPA, 2004a). Also in 
2004, 15 states estimated needing $4.3 billion for reclaimed wastewater distribution 
(EPA, 2008a). California and Florida accounted for 84% of that figure (EPA, 2008a). The 
volume of reclaimed wastewater used is increasing at an approximate rate of 15% per 
year (EPA, 2004a). Reclaimed wastewater is used for a number of reasons including, but 
not limited to: replenishing groundwater supplies, water conservation, additional 
treatment of wastewater, and reduced cost (EPA, 2004a; Levine & Asano, 2004).  
Reclaimed wastewater is used in both potable (sources for drinking water 
treatment plants) and non-potable (land application) projects. Land applications for reuse 
of wastewater can be categorized as low-rate irrigation, overland flow, and high-rate 




choice of reuse method usually depends on site-specific conditions, level of wastewater 
treatment, and intended use of reclaimed wastewater (Maier, 2009; C.-T. Tien, 2010). 
The federal government and individual states are encouraging land application of 
wastewater as an alternative to the traditional discharge of wastewater into surface water. 
Amendments to the Federal Water Pollution Control Act require that during the planning 
phase for new wastewater treatment facilities, land application of wastewater be 
considered as an end use (MDE, 2009). The State of Maryland enacted the Annotated 
Code of Maryland in 2002 to encourage reclaimed wastewater use (MDE, 2009). 
At this time, no federal regulations exist for wastewater reuse, only guidelines. 
Regulations are legally enforceable, whereas guidelines are suggestions for use, but 
cannot be enforced (EPA, 2004a). EPA allows states to determine whether to develop 
regulations or guidelines to oversee the use of reclaimed wastewater within their 
boundaries. As of 2002, 25 states had passed regulations concerning the use of reclaimed 
wastewater, 16 states had developed guidelines, and nine states had neither regulations 
nor guidelines (EPA, 2004a). By 2004, no reclaimed wastewater standards or guidelines 
in the United States were based on microbial risk assessments to determine the risk of 
infection from exposure to reclaimed wastewater (EPA, 2004a). In the past, secondary 
treatment and disinfection were considered standard for reusing treated wastewater (EPA, 
2004a). Even when states do distinguish between effluent from different levels of 
wastewater treatment, they may still allow use of primary and secondary treated 
wastewater, but with additional requirements for buffer zones, as is the case in the State 





As reclaimed wastewater becomes an increasingly common water source, 
assessing possible microbial risks from its use is becoming more crucial for public health. 
In particular, MRSA and VRE are bacteria linked with increased risk of mortality from 
infection and could be excreted into wastewater. If these organisms survive the 
wastewater treatment process, widespread occupational and community exposure could 
occur. Through the findings of my Master’s thesis research, I plan to contribute 
knowledge that may be used for informing environmental management decisions and 
protecting the environment and human health. The detection of pathogenic 
microorganisms in reclaimed wastewater could serve as an impetus to evaluate possible 
improvements to treatment, distribution, and reuse processes. Such findings would also 
have implications for the health of wastewater treatment plant workers and spray 
irrigation workers, as well as other affected members of the community.  
We are facing a future that includes a growing number of states experiencing 
drought conditions with increasing frequency. Reduction of water use and exploration of 
new water sources are both important as we consider irrigation and drinking water needs 
for the future. Reclaimed wastewater has the potential to be an important alternative 
source of water, but before its applications are further expanded, it is important to 









Chapter 3: Short form manuscript: Reductions of Methicillin-
resistant Staphylococcus aureus and Vancomycin-resistant 
Enterococcus spp. at a U.S. Tertiary Wastewater Treatment Plant 
 
Abstract 
Methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant 
Enterococcus spp. (VRE) were isolated from primary and secondary wastewater samples 
at a U.S. tertiary wastewater treatment plant, but not from the effluent. Ninety-seven 
percent of the MRSA isolates were multidrug resistant. These findings suggest that 
tertiary treatment effectively reduces MRSA and VRE. 
Introduction 
As the global, and United States, populations increase, so too do freshwater usage, 
water shortages, and droughts (Angin, et al., 2005; Dobbie, et al., 2008; EPA, 2008b; 
Kocaman, et al., 2007; Levine & Asano, 2004; Rodriguez, et al., 2009; UN, 2003). As 
water shortages become more common, alternative water sources, such as treated 
municipal wastewater, are increasingly being used for downstream applications including 
drinking water treatment plant sources and irrigation (Angin, et al., 2005; Axelrad & 
Feinerman, 2009; Friedel, Langer, Siebe, & Stahr, 2000; Kim & Aga, 2007; Levine & 
Asano, 2004). Because of this practice, individuals exposed to reclaimed wastewater, 
including wastewater and spray irrigation workers, could be exposed to antibiotic-
resistant bacterial pathogens that may remain in treated wastewater. Also, bacteria 
possessing resistance genes to common antibiotics that survive the treatment process 




al., 2009). Antibiotic-resistant bacteria can cause life-threatening infections that have 
limited treatment options (Zhang, et al., 2009). To better understand the potential for 
exposure to antibiotic-resistant bacteria in treated wastewater, it is important to identify 
the presence or absence of these organisms throughout the wastewater treatment process. 
This study evaluates the presence of methicillin-resistant Staphylococcus aureus (MRSA) 
and vancomycin-resistant Enterococcus spp. (VRE) at a tertiary wastewater treatment 
plant located in the Mid-Atlantic region. We hypothesized that wastewater throughout the 
treatment process would contain both MRSA and VRE. 
Methods 
The wastewater treatment plant in this study processes 180 million gallons of 
wastewater per day and uses tertiary treatment, including sand filtration, chlorination, and 
de-chlorination. A total of 18 water samples from the primary (raw untreated) and 
secondary (screened) influent, activated sludge reactor, secondary clarifier, and effluent 
treatment steps were collected on August 3, August 17, October 22, and December 1, 
2009. All samples were collected in 500 milliliter or 1 liter sterile Nalgene collection 
bottles as grab samples. Samples were stored at 4°C during sampling and transportation 
to the laboratory. All samples were processed within 24 hours of collection.  
Standard membrane filtration was used to recover MRSA and VRE from water 
samples (EPA, 2002). Vancomycin-amended membrane-Enterococcus Indoxyl-β-D-
Glucoside agar (Yan, et al.) (EMD Chemicals) was used to isolate VRE. Enterococcus 
spp. were confirmed biochemically by detection of pyrrolidonyl arylamidase activity and 




Filtered samples were enriched for MRSA and total S. aureus using m 
Staphylococcus Broth (BD Diagnostic Systems, Franklin Lakes, NJ). Samples enriched 
for MRSA were plated on MRSASelect  (Bio-Rad Laboratories, Hercules, CA). Samples 
enriched for total S. aureus were plated on Mannitol Salt Agar (BD Diagnostic Systems, 
Franklin Lakes, NJ) and Baird Parker Agar (BD Diagnostic Systems, Franklin Lakes, 
NJ). DNA from presumptive MRSA and S. aureus isolates was extracted using the 
UltraClean Microbial DNA Isolation Kit (Mo Bio Laboratories, Inc, Carlsbad, CA). The 
presence of MRSA was confirmed by PCR amplification of the mecA gene and the S. 
aureus-specific nuc gene. The primers used to detect the nuc and mecA genes were 
NUC1 and NUC2, and MECA1 and MECA2 (Fang & Hedin, 2003). The conventional 
PCR program used for amplification was based on the PCR assay previously described 
by Fang and Hedin in 2003 (Fang & Hedin, 2003).  
Antimicrobial susceptibility testing was performed on MRSA and methicillin-
susceptible S. aureus (MSSA) isolates using the Sensititre microbroth dilution system 
(Trek Diagnostic systems Inc., Cleveland, OH, USA). Samples were grown overnight on 
Trypticase Soy Agar with 5% Sheep Blood (BD Diagnostic Systems, Franklin Lakes, 
NJ). Enterococcus faecalis ATCC 29212 and Staphylococcus aureus ATCC 29213 were 
used as controls for all susceptibility testing. Antimicrobial minimal inhibitory 
concentrations (MICs) were determined using general gram positive plates (GPN3F) 
(Trek Diagnostic systems Inc., Cleveland, OH, USA), and were recorded as the lowest 
concentration of an antimicrobial that inhibited the growth of the bacterial suspension in 




the Clinical and Laboratory Standards Institute (CLSI) standards for antimicrobial 
susceptibility testing (CLSI, 2010). 
Results 
MRSA and MSSA 
A total of 100 MRSA isolates were confirmed from the wastewater samples. 
MRSA was isolated from 43% of influent, 100% of activated sludge reactor, and 67% of 
secondary clarifier samples. To our knowledge, this is the first study to identify MRSA at 
a municipal wastewater treatment plant in the U.S. The percentage of MRSA out of total 
S. aureus isolates grown on non-antibiotic-amended media was highest in the activated 
sludge (40% of isolates) and secondary clarifier (90% of isolates) samples. No MRSA 
was isolated from influent samples grown on non-antibiotic amended plates. No MRSA 
or MSSA was detected in effluent wastewater samples. 
VRE and VSE 
Eighty-seven VRE isolates were isolated from the wastewater samples. VRE was 
present throughout the wastewater treatment process in 100% of influent, activated 
sludge reactor, and secondary clarifier samples. The calculated number of VRE ranged 
from 5 x 103 CFU/mL in primary influent to 1 x 10-1 CFU/mL in the secondary clarifier. 
No VRE was detected in effluent wastewater samples, however vancomycin-susceptible 
Enterococcus spp. (VSE), a fecal indicator, was isolated in the effluent (Figures 2 and 3).  
VRE in the primary influent was higher on August 17, 2009 than samples 
collected at the same location on the other sampling dates by at least one order of 




in both the October and December samples and then decreased in the secondary clarifier 
and effluent. At least one VRE isolate from the primary influent and one isolate from the 
activated sludge reactor samples contained the vanA gene. Previous studies have found 
seasonal differences in the presence of VRE at wastewater treatment plants, with the 
absence of VRE more likely in winter than other seasons (Nagulapally, et al., 2009). 
The concentration of VSE was greater in the raw influent in October than any 
other sampling date (August 3, August 17, and December 1, 2009), with the 
concentration in samples from December second highest. The concentration of VSE in 
the effluent was very low at each collection date, but was highest in the sample from 




The 100 MRSA isolates had a median oxacillin MIC of  ≥16 µg/mL (range, 2 - 
≥16 µg/mL) (Table 1). MRSA isolates also displayed resistance to a number of 
antibiotics approved by the U.S. Food and Drug Administration for treating MRSA 
infections, including linezolid, tetracycline, fluoroquinolones (ciprofloxacin, gatifloxacin, 
and levofloxacin), and clindamycin (Johnson & Decker, 2008). Ninety-seven percent (97 
out of 100) of all MRSA isolates were resistant to ≥ 6 antimicrobial agents. Among 
isolates from the primary influent, 95% were multi-drug resistant, resistant to two or 
more classes of antibiotics (Table 2). One hundred percent of activated sludge reactor and 
secondary clarifier isolates were multi-drug resistant. The MIC distribution for isolates 
from all treatment steps was similar for erythromycin, the penicillins (ampicillin, 




fluoroquinolones increased slightly as treatment progressed (Table 1). Resistance to 
tetracycline and clindamycin was identified only among activated sludge reactor and 
primary influent isolates respectively. The average number of antibiotics that isolates 
were resistant to was greater among the activated sludge reactor isolates than either 
primary influent or secondary clarifier isolates from both October and December 2009 
(Figure 4).  
Sixty-eight percent of the MSSA isolates from all treatment steps were multi-drug 
resistant (Tables 2 and 3). As the treatment process progressed from influent to activated 
sludge reactor to secondary clarifier, the MICs increased for the penicillinase-labile 
penicillins (penicillin and ampicillin), but decreased for the fluoroquinolones. One MSSA 
isolate was resistant to linezolid in the primary influent (Table 3). 
The percentage of MSSA resistant to multiple classes of drugs was greater in 
isolates collected in October 2009 than in December 2009 (Table 2). In the December 
2009 isolates, the percentage of multi-drug resistant (MDR) isolates increased as the 
treatment process progressed, but in the October isolates, the percentage of MDR isolates 
was slightly greater among the influent isolates than the activated sludge reactor isolates 
(Table 2). 
Discussion 
Linezolid and daptomycin are two antibiotics that recently have been considered 
important alternatives for treating severe invasive MRSA infections (Johnson & Decker, 
2008; Kaka, et al., 2006; Loffler & MacDougall, 2007). Only 3% of all MRSA isolates 
were resistant to linezolid. Sixty-seven percent of linezolid-resistant MRSA isolates were 




isolate found to be resistant to linezolid was identified in the primary influent. No MRSA 
or MSSA isolates were found to be resistant to daptomycin. These findings suggest that 
as of yet, the wastewater treatment process decreases the number of isolates with 
resistance to these two more recent antibiotics used in the treatment of severe MRSA 
infections. 
From previous studies it appears that microbial concentration and the 
concentration of antibiotic-resistant bacteria varies throughout the treatment process 
(Börjesson, et al., 2009; Iwane, et al., 2001; Nakamura & Shirota, 1990; Prazmo, et al., 
2003; Rose, 2007). Several studies have concluded that the percentage of antibiotic-
resistant bacteria increases with secondary treatment, peaking in the activated sludge 
reactor, and decreases or is eliminated with tertiary treatments such as ultraviolet 
radiation or chlorination (Börjesson, et al., 2009; Kim & Aga, 2007; Nagulapally, et al., 
2009; Nakamura & Shirota, 1990; Prazmo, et al., 2003; Rose, 2007). Based on the results 
of the present study, and previous studies at wastewater treatment plants, this type of 
pattern seems to depend on the specific organism and antibiotic (Iwane, et al., 2001; 
Nagulapally, et al., 2009; Zhang, et al., 2009). The ratio of MRSA compared to total S. 
aureus did increase as treatment progressed, from 40% in the activated sludge reactor to 
90% in the secondary clarifier. However, the average number of antibiotics that isolates 
were resistant to was greater among the activated sludge reactor isolates than either 
primary influent or secondary clarifier isolates (Figure 4). Further questioning the idea 
that resistance increases from primary to secondary treatment, resistance to tetracycline 
was identified only in primary influent isolates, not in any secondary treatment isolates. 




primary to secondary treatment, while MICs for fluoroquinolones decreased from 
primary to secondary treatment. 
Because VRE were isolated from samples in the primary and secondary treatment 
stages (primary and secondary influent, activated sludge reactor, and secondary clarifier 
steps), it is possible that genes that confer resistance to vancomycin could still be present 
in the effluent and taken up by other bacteria (Courvalin, 2005). These genes and bacteria 
could then be released into a receiving water body or effluent used for reuse applications. 
DNA released from bacteria may persist in environmental samples for a period of time 
(Pote, et al., 2003; Volkmann, et al., 2004).  
 VRE could also be present in effluent, but in a viable but not culturable state 
(Signoretto & Canepari, 2008). Disinfection can reduce the number of culturable 
organisms by injuring cells, but does not always completely eradicate all of the organisms 
(Xi, et al., 2009). A study at a tertiary wastewater treatment plant conducted by Xi et al. 
found that although heterotrophic plate counts decreased by six orders of magnitude 
between raw influent and effluent, the occurrence of 16S rRNA decreased by only one 
order of magnitude, suggesting that injured or dead bacterial cells were still present (Xi, 
et al., 2009). Both E. faecalis and E. hirae have been found to able to resume cell 
reproduction after being in a viable but not culturable state upon entering a favorable 
environment (Lleò, et al., 2001; Signoretto & Canepari, 2008). Also, only approximately 
5 to 10% of bacteria found in wastewater is culturable at all (Hiraishi, 1998; Xi, et al., 
2009). Even the presence of total Enterococcus spp. in effluent samples is important, as 
they are indicator organisms used to determine the presence of other fecal pathogens. So, 




that using tertiary treated wastewater in reuse applications has zero risk of exposing 
individuals to these pathogens and/or antibiotic resistance genes. 
Although no MRSA or VRE were isolated from the effluent at the tertiary 
wastewater treatment plant, both MRSA and VRE were recovered in all other wastewater 
samples, including the secondary clarifier, which is the last step in the secondary 
treatment process. Secondary treatment is the highest level of treatment required of 
municipal wastewater treatment facilities by the United States Environmental Protection 
Agency (EPA) and consists of removing suspended organic solids through biological 
processes. Tertiary treatment is any type of treatment beyond secondary treatment. As of 
2004, approximately 100 million individuals living in the United States were serviced by 
secondary, or less than secondary, wastewater treatment facilities (9,261 facilities). If the 
effluent from these facilities, which comprise over half of the municipal wastewater 
treatment facilities in the U.S., is reused in irrigation or other reuse activities, a large 
percentage of the U.S. population could be exposed to MRSA and VRE (USEPA, 2004, 
2008). 
Conclusions 
In conclusion, MRSA and VRE were found throughout the secondary wastewater 
treatment process at a tertiary wastewater treatment facility in the Mid-Atlantic region. 
High levels of multi-drug resistance in MRSA and MSSA were prevalent throughout the 
treatment process, 97% and 68% respectively, but increased slightly from primary to 
secondary treatment. To our knowledge, this is the first time that MRSA has been 
isolated from a wastewater treatment plant in the United States. Because secondary 




treatment facilities in the United States, the public health implications of exposure to, and 
reuse of, secondary treated wastewater could be significant. As the use of reclaimed 
wastewater accelerates across the United States, the risk of antibiotic-resistant bacterial 
infections from exposure to treated wastewater, from both secondary and tertiary 





Figure 2. Colony forming units (CFU) per milliliter (CFU/mL) of vancomycin-susceptible 





Figure 3. Colony forming units (CFU) per milliliter (CFU/mL) of vancomycin-resistant Enterococcus 





Figure 4. Average number of antibiotics that MRSA isolates display resistance to in different 
treatment steps of a tertiary wastewater treatment facility in the Mid-Atlantic Region (n = total 




aDid not isolate any MRSA from secondary clarifier October 2009 samples. 
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Table 2. Percentage of multidrug resistant methicillin-resistant S. aureus (MRSA) and methicillin-













Chapter 4: Antibiotic-Resistant Bacteria Present in Reclaimed 
Wastewater and Occupational Exposure at a Spray Irrigation Site 
 
Abstract 
As water shortages become more common, reclaimed wastewater is increasingly 
being used for irrigation activities. Because of this practice, spray irrigation workers 
could be exposed to pathogens and antibiotic-resistant bacteria that may remain in treated 
wastewater. This study evaluated the presence of vancomycin-resistant Enterococcus spp. 
(VRE) and methicillin-resistant Staphylococcus aureus (MRSA) in reclaimed 
wastewater, air, and nasal and dermal swabs of employees at a spray irrigation site in the 
Mid-Atlantic region of the United States. Water, air, and swab samples were processed 
for MRSA and VRE using centrifugation, standard membrane filtration, and direct 
plating. Vancomycin-amended membrane-Enterococcus Indoxyl-β-D-Glucoside agar (m 
EI) and MRSASelect were used to isolate VRE and MRSA, respectively. The presence of 
MRSA and S. aureus was confirmed by PCR amplification of the mecA gene and the S. 
aureus-specific nuc gene. VRE was confirmed biochemically. Antimicrobial 
susceptibility testing was performed using the Sensititre microbroth dilution system. 
Enterococcus spp. was isolated in all water samples except after on-site ultraviolet 
radiation treatment. VRE was identified in a sample from a storage pond at the point of 
the inlet to the pumphouse that distributes the reclaimed wastewater to the irrigation 
system. No MRSA or methicillin-susceptible S. aureus (MSSA) was identified in any of 
the water samples. No MRSA, MSSA, VRE, or Enterococcus spp. were identified in air 




colonization (31%) when compared to a control group (46%), however a greater 
percentage of isolates from spray irrigation workers were multidrug resistant (25% vs. 
17%). Our findings suggest that UV treatment effectively reduces Enterococcus spp. 
found in reclaimed wastewater but that open-air storage of UV-treated reclaimed 
wastewater can lead to recontamination with these organisms. The higher percentage of 
multidrug resistant S. aureus among spray irrigation workers compared to controls could 
be cause for concern and deserves additional research to evaluate whether there is a 
significant association with exposure to reclaimed wastewater. 
Introduction 
Spray irrigation is increasingly relying on reclaimed wastewater, resulting in 
potential exposures among spray irrigation workers to water that could contain biological 
contaminants as well as antibiotics (Angin, et al., 2005; Kocaman, et al., 2007). As 
droughts and water shortages become more common across the United States and the 
world, cities are using reclaimed wastewater for spray irrigation applications, as well as 
source water for drinking water treatment plants. Staphylococcus aureus and 
Enterococcus spp. are organisms that are commonly found on the skin and in the 
intestinal tracts of animals and humans that under certain conditions can cause potentially 
fatal diseases (Centers for Disease Control and Prevention (CDC), 2008; FDA, 2009; 
Murray, et al., 2002; Rusin, et al., 2003; Spacek & Vinetz, 2009). The emergence of 
antibiotic-resistant strains of S. aureus and Enterococcus spp. means that there is a risk 
that the illnesses caused by these bacteria might no longer be treatable with traditional 
antibiotics, posing significant risks to public health. If pathogens and antibiotic-resistant 




process, spray irrigation workers using reclaimed wastewater could be exposed to these 
harmful agents. 
Goals 
One goal of our study was to evaluate the presence of methicillin-resistant 
Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus spp. (VRE) in 
reclaimed wastewater used for spray irrigation and air samples from the spray irrigation 
site. We also sought to determine the prevalence of MRSA, VRE, S. aureus, and 
Enterococcus spp. in nasal and dermal swab samples collected from spray irrigation 
workers, an occupational group with high levels of exposure to reclaimed wastewater. 
Hypothesis: Antibiotic-resistant S. aureus and Enterococcus spp. will be present 
in water, air, and dermal and nasal swab samples collected during wastewater irrigation 
activities.  
The results of this study have implications not only for occupational exposures 
among spray irrigation workers, but also for the general public whose recreation areas 
might be irrigated with reclaimed wastewater or who consume drinking water that 




Samples were collected from a spray irrigation site located in the Mid-Atlantic 
region of the United States. The spray irrigation site receives treated wastewater from a 




treated wastewater from the treatment plant to a nearby steel mill. The spray irrigation 
site uses a polyvinyl chloride pipe connection to divert a segment of the treated 
wastewater from the discharge pipeline to the spray irrigation site before it reaches the 
steel mill. Once the treated wastewater reaches the spray irrigation site, it passes through 
an approximately two-foot long, double-walled aluminum screen and is then treated with 
ultraviolet (UV) radiation (Figure 5). After UV treatment, the water is pumped into an 
open-air pond at a rate of 230,000 gallons per day (Figure 5). The storage pond can hold 
up to 4 million gallons of water. Based on irrigation needs, water is then pumped from 
the holding pond to a shed that contains a pump to distribute the water to the appropriate 
spray heads (Figure 5). The spray irrigation site employs eight full-time employees and 
approximately 22 seasonal employees each year. 
Sample Collection 
Spray irrigation water and nasal and dermal swab samples were collected in 
August and October 2009. Air samples were collected in August, but not October 2009, 
because of precipitation that interfered with sample collection. Meteorological data were 
collected during each sampling trip. 
Water 
A total of eight water samples from before and after on-site UV radiation 
treatment (“Before UV” and “After UV”), input to the storage pond (“Input to Pond”), 
and inlet to the pumphouse from the pond (“Inlet to Pumphouse”) were collected on 
August 17 and October 27, 2009 (Figure 5). All samples were collected in 500 mL or 1 L 




and transportation to the laboratory. All samples were processed within 24 hours of 
collection. 
Air 
 On August 17, 2009 two air samples each were collected in the range of spray 
heads and at a control site that is not irrigated with reclaimed wastewater. Samples were 
collected using SKC BioSamplers (SKC, Eighty Four, PA). The BioSamplers were filled 
with 20 mL of phosphate buffered saline (PBS) and run for one hour at each sampling 
location. Thirty minutes into sampling, the BioSamplers were turned off, the volume of 
PBS in the collection vessel was measured, and distilled water was added until the 
volume was 20 mL again. Samples were stored at 4°C during sampling and transportation 
to the laboratory. Air samples were processed within 24 hours of collection. 
Nasal and Dermal Swabs 
Nasal and dermal swab samples were collected from a convenience sample of 13 
spray irrigation workers who were available on August 17, 2009 at the time of sample 
collection. On October 27, 2009, nasal and dermal swabs were collected for a second 
time from three available participants, spray irrigation workers 1, 2, and 4. Swabs were 
collected to evaluate inhalation and dermal exposures to pathogens from reclaimed 
wastewater. Between September and November 2009, nasal and dermal swabs were also 
collected from a control group of office workers from a site that is not exposed to 
reclaimed wastewater. Office worker controls were age- and gender-matched to the spray 
irrigation study population. 
Nasal swabs were collected using a rayon-tipped plastic applicator pre-moistened 




centimeters into the participant’s right nostril and gently rotated five times on the inside 
wall of the nostril.  
Dermal swabs were also collected using a rayon-tipped plastic applicator pre-
moistened in Stuart’s transport media (Copan, Italy). An approximately five-by-five 
centimeter area of the participant’s right forearm was swabbed with the rayon-tipped 
applicator by rolling the swab back and forth 15 times (Kullander, Forslund, & Dillner, 
2009).  
After sample collection, nasal and dermal swabs were inserted into Stuart’s 
transport media, stored at 4°C during transportation to the lab, and processed within 24 
hours of collection. 
Questionnaire 
 
A questionnaire was provided to all study participants to collect demographic and 
occupational information (Appendix B). Participants also were asked about risk factors 
that could increase the likelihood of S. aureus or MRSA colonization, such as whether 
they had ever personally worked in a healthcare setting and if anyone in their household 
had ever worked in a healthcare setting (Table 5). 
Isolation 
Isolation of S. aureus and MRSA from Water Samples 
August Samples 
Water samples collected in August were isolated based on a technique used by 
Börjesson et al. (2009) to recover S. aureus and MRSA from wastewater samples 




minutes. The resulting pellet was enriched in either Luria-Bertani Miller (LB Miller) 
Broth (BD Diagnostic Systems, Franklin Lakes, NJ) amended with cefoxitin and 
aztreonam or m Staphylococcus Broth (BD Diagnostic Systems, Franklin Lakes, NJ) to 
isolate MRSA and S. aureus, respectively. Enriched samples were incubated at 37°C for 
24 hours. Samples enriched in amended LB Miller Broth were plated on MRSASelect 
(Bio-Rad Laboratories, Hercules, CA). Samples enriched in m Staphylococcus Broth 
were plated on Mannitol Salt Agar (MSA) (BD Diagnostic Systems, Franklin Lakes, NJ). 
October Samples 
Standard membrane filtration was used to isolate MRSA and S. aureus from 
October 27, 2009 water samples. 300 mL of each sample were filtered through 0.45 µm 
cellulose filters (Millipore, Billerica, MA). Filtered samples were enriched for MRSA 
and S. aureus in 40 mL of LB Miller Broth amended with cefoxitin and aztreonam and m 
Staphylococcus Broth. Enriched samples were then incubated at 37°C for 24 hours. 
Samples enriched in amended LB Miller Broth were streaked onto MRSASelect with a 
calibrated 10 µL loop. Samples enriched in m Staphylococcus Broth were streaked onto 
MSA, Baird Parker Agar (BD Diagnostic Systems, Franklin Lakes, NJ), and 
MRSASelect with a calibrated 10 µL loop.  
 
Isolation and Enumeration of Enterococcus spp. from water 
Standard membrane filtration, based on U.S. Environmental Protection Agency 
(EPA) Method 1600, was used to isolate VRE and other Enterococcus spp. from water 
samples ((EPA), 2002). One liter, 300 mL, and 100 mL of Before UV, After UV, and 




filtered through 0.45 µm cellulose filters (Millipore, Billerica, MA). Filters were then 
placed on membrane-Enterococcus Indoxyl-β-D-Glucoside agar (m EI) (EMD 
Chemicals) and mEI amended with 16 µg/mL vancomycin to isolate Enterococcus spp. 
and VRE respectively and incubated for 24 hours in a circulating water bath set at 41°C. 
Colonies with a blue halo, regardless of the actual colony color, were 
presumptively identified as Enterococcus spp. Using plates with between 30 and 300 
colony forming units, enumeration of the concentration of Enterococcus spp. and VRE 
per 1 mL of water was calculated. 
 
Isolation of S. aureus and Enterococcus spp. from nasal and dermal swabs 
 
 Nasal and dermal swabs were streaked onto MSA and Baird Parker Agar for 
isolation of S. aureus and onto Enterococcosal Agar (BD Diagnostic Systems, Franklin 
Lakes, NJ) for isolation of Enterococcus spp. MSA and Baird Parker Agar plates were 
incubated at 37°C for 24 hours while the Enterococcosal Agar plates were incubated at 
41°C for 24 hours. 
 
Isolation of S. aureus and Enterococcus spp. from air samples 
  
 Standard membrane filtration was used to filter 10 mL of each air sample through 
0.45 µm cellulose filters. Filters were then enriched in m Staphylococcal Broth and 
Enterococcosel Broth (BD Diagnostic Systems, Franklin Lakes, NJ) to enrich for S. 
aureus and Enterococcus spp. respectively. m Staphylococcal Broth was incubated for 24 
hours at 37°C while Enterococcosel Broth was incubated at 41°C for 24 hours. A 10 µL 




37°C. A 10 µL loop of Enterococcosel broth was streaked onto EA and incubated at 41°C 
for 24 hours. 
 
Identification 
Identification of S. aureus from water, air, and swab samples 
 Presumptive S. aureus isolates were identified as yellow colonies with yellow 
precipitate on MSA and shiny black colonies with a clear halo on Baird Parker Agar. 
Presumptive MRSA isolates were identified as bright pink colonies on MRSASelect. 
Presumptive colonies underwent a series of biochemical tests to further confirm their 
identification as S. aureus or MRSA. Gram staining, catalase testing, and coagulase 
testing were performed on all presumptive S. aureus and MRSA isolates. All isolates 
appearing as Gram-positive cocci, with positive catalase and coagulase tests were 
confirmed as presumptive S. aureus and MRSA. 
DNA from presumptive MRSA and methicillin-susceptible S. aureus (MSSA) 
isolates was extracted using the UltraClean Microbial DNA Isolation Kit (Mo Bio 
Laboratories, Inc, Carlsbad, CA). The presence of MRSA and MSSA was confirmed by 
PCR amplification of the mecA gene and the S. aureus-specific nuc gene. The primers 
used to detect the nuc and mecA genes were NUC1 and NUC2, and MECA1 and MECA2 
(Fang & Hedin, 2003). An internal control of a 16S rRNA gene was added to the PCR 
duplex. The conventional PCR program used for amplification was based on the PCR 





Identification of Enterococcus spp. from water, air, and swab samples 
Enterococcus spp. and VRE were confirmed biochemically by Gram staining, 
detection of pyrrolidonyl arylamidase activity with a PYR test, and the ability of the 
bacterium to break down hydrogen peroxide by catalase. All isolates appearing as Gram-
positive cocci, with negative catalase, and positive PYR tests were confirmed as 
Enterococcus spp. and VRE. 
 
Antimicrobial susceptibility testing 
Antimicrobial susceptibility testing was performed on MRSA and MSSA isolates 
using the Sensititre microbroth dilution system (Trek Diagnostic systems Inc., Cleveland, 
OH, USA). Samples were grown overnight on Trypticase Soy Agar with 5% Sheep 
Blood (BD Diagnostic Systems, Franklin Lakes, NJ). Enterococcus faecalis 29212 and S. 
aureus 29213 were used as controls for all susceptibility testing. Antibiotic minimal 
inhibitory concentrations (MICs) were determined using general gram-positive plates 
(GPN3F) (Trek Diagnostic systems Inc., Cleveland, OH, USA), and were recorded as the 
lowest concentration of an antimicrobial that inhibited the growth of the bacterial 
suspension in Mueller-Hinton Broth (Beier, et al., 2008). Resistance breakpoints were 
determined using the Clinical and Laboratory Standards Institute (CLSI) standards for 






We did not identify MSSA or MRSA in any of the spray irrigation water samples. 
Enterococcus spp. was isolated from Before UV, Input to Pond, and Inlet to Pumphouse 
samples. The concentration of Enterococcus spp. was undetectable in the After UV 
samples in both August and October. The concentration of Enterococcus spp. increased 
between Input to Pond and Inlet to Pumphouse samples by three orders of magnitude in 
August and October (Figure 6). A concentration of 1 x 10-2 colony forming units/mL of 
VRE was detected in a sample taken from the Inlet to the Pumphouse in October (Figure 
6). No VRE was isolated from any samples in August. At this time, we have not 
identified whether the Enterococcus spp. or VRE we found in the spray irrigation water 
samples can be traced to human or animal strains. 
The levels of Enterococcus spp. in the Before UV samples, which came directly 
from the wastewater effluent, were highest in the samples collected on August 17, 2009. 
The concentration of Enterococcus spp. in the treated municipal wastewater effluent was 
also higher in August than October 2009 (refer to Chapter 3). The concentrations of 
Enterococcus spp. in the Input to Pond and Inlet to Pumphouse samples were slightly 
higher on October 27 compared to August 17. 
Air 
No MRSA, VRE, MSSA, or Enterococcus spp. was isolated from air samples 




Nasal and Dermal Swabs 
Thirty-one percent of spray irrigation workers exposed to reclaimed wastewater 
were colonized with MSSA in their right naris. Of the three spray irrigation workers 
swabbed on both August 17 and October 27, 2009, worker 1 was not colonized with S. 
aureus on either occasion, worker 2 was colonized in August but not October, and worker 
4 was colonized on both dates (Table 4). None of the spray irrigation workers’ dermal 
swabs were positive for S. aureus. Among the control group of office workers, there was 
a 46% rate of nasal colonization with MSSA. A dermal swab isolate from one office 
worker control (7.7%) was positive for MSSA. Based on the PCR duplex for the mecA 
and nuc genes, none of the nasal or dermal swab isolates from spray irrigation workers or 
office workers were identified as MRSA. However, one isolate from spray irrigation 
worker 13 possessed the mecA gene and was identified as methicillin-resistant coagulase 
negative S. aureus (MR-CoNS) (Table 4). None of the nasal or dermal swabs from the 
spray irrigation workers or office workers were positive for VRE or Enterococcus spp.  
The spray irrigation and office workers had a similar percentage of MSSA nasal 
isolates that were resistant to ampicillin and pencillin, but differed in resistance to 
erythromycin, tetracycline, and linezolid (Figure 7). From the spray irrigation workers, 
75% of the MSSA nasal swab isolates were resistant to at least one antibiotic and 25% of 
isolates (one out of four) were multidrug resistant, resistant to two or more classes of 
antibiotics (Table 4). Sixty-seven percent of office worker nasal swab MSSA isolates 
were resistant to one or more antibiotic (Table 4). Seventeen percent of MSSA nasal 
swab isolates from office workers, one out of six MSSA isolates, were multidrug 




1.33 among the spray irrigation worker and office worker nasal swab isolates 
respectively. 
The MSSA isolate from office worker 7’s dermal swab was multidrug resistant to 
high concentrations of erythromycin, ampicillin, and penicillin (Table 4). 
The MR-CoNS isolate from spray irrigation worker 13 was multidrug resistant to 
oxacillin, penicillin, and tetracycline (Table 4). 
The odds ratio of being colonized with MSSA as a spray irrigation worker versus 
an office worker control was 0.52 (95% CI, 0.10-2.60), meaning that the office workers 
in this study were 1.93 times more likely to be colonized with MSSA as the spray 
irrigation workers, but this association was not statistically significant. 
Both of the spray irrigation workers (n=2) who reported having a household 
member who had ever worked in a healthcare setting had MSSA positive nasal swabs. 
However, only 60% of office worker controls (three out of five) who reported having a 
household member who had ever worked in a healthcare setting had MSSA positive nasal 




In August and October 2009, we analyzed reclaimed wastewater used for spray 
irrigation, air, and nasal and dermal swab samples at a site in the Mid-Atlantic region for 
the presence of MRSA, MSSA, VRE, and Enterococcus spp. To our knowledge, this is 
the first study to evaluate the presence of antibiotic-resistant bacteria in reclaimed 




States. Our results suggest that concentrations of gram-positive antibiotic-resistant 
bacteria present in wastewater are significantly reduced through disinfection, but can still 
survive in varying degrees in reclaimed wastewater used for spray irrigation. 
The finding that Enterococcus spp. were isolated in Before UV but not After UV 
samples suggests that UV treatment successfully reduced the amount of Enterococcus 
spp. to an undetectable level. In terms of MRSA, Tolba et al. found that a free 
chlorination concentration of 2.9 ppm killed both hospital- and community-acquired 
MRSA (Tolba, et al., 2008). The wastewater treatment plant supplying treated 
wastewater to the spray irrigation site uses chlorine as a method for disinfection. Bleach 
is added to the wastewater in the chlorination step to give a concentration of chlorine of 2 
or 3 ppm. The concentration of chlorine used could have been high enough to eradicate 
all viable S. aureus from the reclaimed wastewater. Also, depending on how long it takes 
the treated wastewater to travel from the wastewater treatment plant to the spray 
irrigation site, there could be die-off of any residual S. aureus in the wastewater effluent 
in the distribution system. Tolba et al. found that there is significant die-off of MRSA 
after 14 days in both fresh and saline water (Tolba, et al., 2008). Enterococcus spp., 
however, can survive between 14 and 50 days in water, which could explain the presence 
of Enterococcus spp. but not S. aureus in the Before UV samples (Signoretto & Canepari, 
2008). 
The spike in the concentration of Enterococcus spp. in the Inlet to Pumphouse 
samples, which were collected from the open-air storage pond, suggests that 
recontamination of the reclaimed wastewater could had occurred. Enterococcus spp. is a 




the storage pond from animal or avian fecal matter. If animal or avian sources were the 
cause of the increase of Enterococcus spp. concentrations in the Inlet to Pumphouse 
samples, covering the storage pond would protect reclaimed wastewater supplies from 
exposure to animals and runoff, which might also contain fecal contaminants. Pathogens, 
including antibiotic-resistant bacteria, introduced into the storage pond by animals could 
pose a risk of infection to spray irrigation workers and other individuals at the spray 
irrigation site. Antibiotic-resistant bacteria, including MRSA and VRE, can move from 
animals to the environment and from environmental media to humans (Kuhn, et al., 2005; 
Moodley, et al., 2008; Smith, et al., 2009; Van Belkum, et al., 2008).  
However, the possibility also exists that Enterococcus spp. were reduced to a 
viable but not culturable state after UV treatment, and the pond environment allowed 
them to recover and reproduce (Signoretto & Canepari, 2008). Previous studies have 
found that only 5 to 10% of bacteria found in wastewater are culturable (Hiraishi, 1998; 
Xi, et al., 2009). Disinfection might reduce the number of culturable organisms by 
injuring cells, but not completely kill the organisms (Xi, et al., 2009). Although 
heterotrophic plate counts decreased by six orders of magnitude between influent raw 
wastewater and disinfected effluent in one study, the occurrence of 16S rRNA, a type of 
RNA that encodes for protein production in prokaryotes, decreased by only one order of 
magnitude (Xi, et al., 2009). E. faecalis and E. hirae have been shown to be able to 
resume cell reproduction after being in a viable but not culturable state upon entering a 
favorable environment (Lleò, et al., 2001; Signoretto & Canepari, 2008). 
The finding that S. aureus was not identified in any of the spray irrigation samples 




killed in the tertiary treatment step (chlorination, de-chlorination, and filtration) at the 
wastewater treatment plant where the wastewater originated. In Chapter 3 of the present 
thesis, MRSA and S. aureus were identified in all wastewater samples except for effluent. 
Also, because S. aureus typically occurs in low concentrations in water, and because we 
collected only eight grab samples from the spray irrigation site, by chance we might have 
collected samples that did not contain S. aureus, even if it was present (Tolba, et al., 
2008). Also, although many studies have compared various isolation techniques for 
MRSA, the majority of the existing protocols for isolating MRSA were developed for 
clinical swab specimens. Protocols for culturing clinical specimens were taken into 
account when developing the protocol for the present study, but organisms behave 
differently in different environments. The protocol used to isolate MRSA and S. aureus 
in August was not successful, even with influent wastewater samples that on other 
sampling occasions, with the protocol followed in October, were always positive for 
MRSA and MSSA. Also, although MSA has previously been found to work well in low 
prevalence areas, we experienced overgrowth (Smyth, et al., 2001). The overgrowth 
observed on MSA could have been the manifestation of out competition of S. aureus and 
MRSA by other bacteria. The inhibitory influence of other bacteria on the growth of 
MRSA has been documented previously (Grmek-Kosnik, et al., 2005). 
Although we did not identify MRSA or VRE in reclaimed wastewater samples at 
the spray irrigation site through culture methods, there could be free antibiotic resistance 
genes in the reclaimed wastewater piped to the irrigation site. DNA released from 
bacteria may remain in water without degrading for varying amounts of time (Pote, et al., 




presence of the mecA and vancomycin resistance van genes in reclaimed wastewater 
spray irrigation samples is an area for future investigations. 
Air 
The absence of S. aureus and Enterococcus spp. from the air samples collected in 
this study could be more the result of the type of sampling equipment used than an actual 
lack of these organisms in the air at the spray irrigation site. In a study by Chang et al. 
(2001), although Staphylococcus and Micrococcus were the dominant aerosolized 
bacterial species in their samples, the vigorous scrubbing that takes place in impingers 
was suspected of breaking up bacterial clusters and reducing the number of viable 
organisms (Chang, Chung, Huang, & Su, 2001; Thorne, Kiekhaefer, Whitten, & 
Donham, 1992). In low concentration situations, such as the open-air spray irrigation site, 
impactors are usually more efficient than impingers (Lundholm, 1982; Thorne, et al., 
1992). A study by Thorne et al. found that for collecting aerosolized enteric bacteria, only 
multi-stage impactors consistently recovered the bacteria compared to impingers and 
filters (73% data yield) (Thorne, et al., 1992). In future iterations of this study, spray 
irrigation site air samples should be collected using impactors instead of impingers. 
Nasal and Dermal Swabs 
S. aureus prevalence among the spray irrigation workers in our study was 31%, 
slightly higher than the prevalence recorded in the general population (20-30%) (Bassetti, 
et al.; John & Barg, 1999). Although the total prevalence of MSSA was higher in our 
control population (46%) than in our spray irrigation worker study population, a greater 
percentage of nasal swab isolates from spray irrigation workers were multidrug resistant, 




average number of antibiotics that isolates were resistant to, was slightly higher among 
the spray irrigation worker (1.75) than the office worker (1.33) isolates. A direct 
association between the level of antibiotic resistance and multidrug resistance patterns 
among MSSA isolates and exposure to reclaimed wastewater cannot be determined in the 
current study. However, these results suggest that additional sampling efforts should be 
conducted and a greater number of samples should be collected to determine if the higher 
percentage of multidrug resistant MSSA isolates among spray irrigation workers is 
statistically significant and if it is associated with exposure to reclaimed wastewater. 
The subject population in the current study was mostly young to middle-aged 
(median age = 32 years) Caucasian males that are concurrently exposed to chemical 
pesticides and fertilizers. Although previous studies have found that male gender and 
young age are risk factors for S. aureus nasal colonization, the study population’s 
exposure to chemical substances and water might interact with pathogens in the body 
with varying results (Gorwitz, et al., 2008; Halablab, Hijazi, Fawzi, & Araj, 2009). A 
study by Halablab et al. found that washing the nasal passages with water more than 
twice daily was significantly associated with lower S. aureus nasal colonization rates 
(Halablab, et al., 2009). Halablab et al. explains this association by hypothesizing that 
water may interfere with adherence of S. aureus in the nasal passages (Beachey, 1981; 
Halablab, et al., 2009). As spray irrigation workers are by definition routinely exposed to 
water, this could help explain why the prevalence of MSSA was lower in the spray 
irrigation workers than the office worker controls. 
The frequent application of chemical substances at the study site could also have 




chemicals could cause irritation of skin and mucous membranes, hindering the body’s 
ability to protect against bacterial infections (D. Lewis, Gattie, Novak, Sanchez, & 
Pumphrey, 2002). S. aureus in particular has been noted to preferentially invade irritated 
tissue (Brook, 1992; D. Lewis, et al., 2002; Leyden & Kligman, 1978). Although the 
prevalence of S. aureus in this study was not higher among spray irrigation workers than 
office worker controls, additional research into the interaction between chemicals and 





To provide a more complete picture of exposure to antibiotic-resistant bacteria 
from reclaimed wastewater used for spray irrigation we would need to collect additional 
samples at the site used in the current study, as well as samples from additional spray 
irrigation sites. In the current study we collected swab samples only once from the entire 
study population, and twice from three participants. Additional swab samples would help 
to capture seasonal variations, and determine if participants colonized with S. aureus are 
continuous or intermittent carriers. Additional sampling trips would also help us evaluate 
seasonal variability in MRSA and VRE isolated from water samples. Wastewater 
treatment plants across the United States apply different levels of treatment (secondary or 
tertiary) and use a variety of tertiary treatment techniques (filtration, UV radiation, 




of antibiotic-resistant bacteria in effluent wastewater transported to spray irrigation site, 
as well as occupational exposure levels. 
Water 
In this study, we did not collect measurements on water parameters such as 
temperature, dissolved oxygen, pH, and salinity. All of these environmental parameters 
could have affected the survival of the pathogens of interest. 
Some of the Enterococcus spp. isolated on non-vancomycin-amended mEI, could 
be VRE. To identify additional VRE isolates, and determine antimicrobial susceptibility 
patterns, a combination of PCR, to identify possession of van genes, and antimicrobial 
susceptibility testing would be needed. 
To estimate the source of Enterococcus spp. and VRE isolated at the spray 
irrigation site, identification of the isolates to the species, and potentially strain, level is 
needed. To determine if the vancomycin resistance genes possessed by the VRE isolates 
found in the Inlet to the Pumphouse samples are acquired or intrinsic, the specific van 
genes need to be identified. 
Nasal and Dermal Swabs 
The small sample size of the spray irrigation worker population was a major 
limitation in the current study. Previous studies have found low carriage rates of MRSA 
in the community, for instance in the range of 0.70-3.9% among veterinary professionals 
and 0.6% in a religious community (Coronado, et al., 2007; Moodley, et al., 2008). 
Because our sample size was so small, it would have been largely due to chance to collect 
swabs from a spray irrigation or office worker that was colonized with MRSA. The small 




The nares are the most common body site to screen for S. aureus colonization, but 
they are not the only common sites of colonization. The throat, perineum, axilla, and 
groin are also important reservoirs of S. aureus in, or on, the body (Bassetti, et al., 2005; 
Gorwitz, et al., 2008; Grmek-Kosnik, et al., 2005; Mertz, et al., 2007). Several studies 
have found that screening for S. aureus from only one body site, including the nares, can 
lead to false negative results (A. Currie, et al., 2008; Grmek-Kosnik, et al., 2005; Mertz, 
et al., 2007; Meurman, Routamaa, & Peltonen, 2005). By only swabbing the right nostril 
and right forearm of spray irrigation and office workers, we could be underestimating the 
prevalence of S. aureus in both populations. At a minimum, nasal swabs are usually 
collected from both nares, however, our approved Institutional Review Board Human 
Subjects Testing document only allowed us to sample from the right nare and right 
forearm (Bassetti, et al., 2005; Gorwitz, et al., 2008; Ohara-Nemoto, Haraga, Kimura, & 
Nemoto, 2008; Schuenck, et al., 2006). 
Although the percentage of multidrug resistant MSSA isolates was higher among 
spray irrigation workers than the office worker controls, the spray irrigators could be 
exposed to S. aureus from a source other than reclaimed wastewater. Although they are a 
direct measure of exposure levels, samples such as nasal and dermal swabs do not 
provide information on the source of exposure. Without evaluating the presence of 
resistance genes in spray irrigation water samples with a total DNA extraction, and 
without determining the specific strains of S. aureus in nasal swab samples, we are 
unable to determine if reclaimed wastewater used for spray irrigation was the source of 
resistance in S. aureus isolated from nasal swabs. Even using these methods, it could be 





The low concentrations of VRE found in the reclaimed wastewater spray 
irrigation samples and the absence of MRSA from these samples, suggests that reclaimed 
wastewater from tertiary treatment, with UV treatment and covered storage, can be used 
as a source of spray irrigation with a low risk of exposure to gram-positive, antibiotic-
resistant bacteria. However, as this is the first study of its kind, the public health risks 
from exposure to reclaimed wastewater need to be explored further. Based on the 
increase in Enterococcus spp. concentration and detection of VRE in the open-air storage 
pond used to store reclaimed wastewater for spray irrigation, it seems prudent to store the 
water in a covered location. Covering the reclaimed wastewater could help prevent 
possible fecal contamination from wildlife and the addition of other contaminants from 
surface runoff into the pond.  
The occurrence of multidrug resistant MSSA among spray irrigation workers 
could be cause for concern. Additional research is needed to determine whether the 
higher percentage of multidrug resistant MSSA among spray irrigation workers compared 








Figure 6. Concentration of Enterococcus spp. and vancomycin-resistant Enterococcus spp. in 






Figure 7. Percentage of methicillin-susceptible Staphylococcus aureus nasal swab isolates from spray 














Table 4. Minimum inhibitory concentrations (MICs) of select Staphylococcus aureus and 
methicillin-resistant coagulase negative Staphylococcus isolates from spray irrigation and office 
workers’ nasal and dermal swabs 
aMethicillin-susceptible Staphylococcus aureus. 
bMethicillin-resistant coagulase negative Staphylococcus spp. (MR-CoNS) isolate. 
cNasal swab taken from Spray Irrigation Worker4 in October. Swabs were taken from only Worker1, 
2, and 4 in both August and October. Worker4 was the only participant with persistant colonization. 












Reclaimed wastewater is already being used across the United States and around 
the world, but limited studies have been conducted on the potential public health risks 
from exposure to this source of water (Rose, 2007; Rose, et al., 1999). In terms of water 
conservation, reuse of treated wastewater has enormous potential and could be a boon for 
protecting against degradation and drawdown of surface water sources. However, before 
the number of wastewater reuse applications continues to grow, to be cautious in order to 
avoid possible human health risks, additional research is needed on the types and 
concentrations of contaminants in reclaimed wastewater.  
The research described in this thesis sought to begin the process of evaluating 
possible health risks associated with exposure to antibiotic-resistant bacteria that may be 
present in reclaimed wastewater. This study only analyzed reclaimed wastewater at a 
spray irrigation site being used for landscaping purposes. It should be noted that 
reclaimed wastewater is also currently being used to irrigate agricultural fields and as a 
source for drinking water treatment plants, among other applications (EPA, 2004a; 
Levine & Asano, 2004). Although this thesis research evaluated occupational exposure to 
reclaimed wastewater, because of its wide use, individuals in the general public are also 
exposed to reclaimed wastewater.  
In conclusion, the results of this thesis project suggest that tertiary treatment 




reclaimed wastewater samples used for spray irrigation that have undergone additional 
on-site UV treatment. MRSA and VRE were, however, isolated from influent, activated 
sludge, and secondary clarifier wastewater samples. Our findings suggest that secondary 
treatment is not effective at eradicating MRSA and VRE in wastewater effluent that 
ultimately could be used in downstream applications. If this is the case, then 
approximately 100 million individuals in the United States, serviced by secondary 
treatment, or less than secondary treatment, wastewater facilities (9,261 facilities) could 
be exposed to antibiotic-resistant bacteria if reclaimed wastewater from secondary 
treatment facilities is allowed for irrigation applications in their state (Figure 8) (EPA, 
2008a). 
This was the first published study to isolate MRSA from a wastewater treatment 
plant in the United States. The isolation methods for S. aureus and MRSA from water are 
still in their infancy, so our results could be underestimating the total S. aureus and 
MRSA present in wastewater and spray irrigation water samples (Börjesson, et al., 2009). 
Even low concentrations of MRSA in treated wastewater could present health risks to 
individuals with high sensitivity or high levels of exposure, i.e. wastewater treatment 
plant and spray irrigation workers. The presence of MRSA in wastewater samples also 
represents a risk for transfer of resistance genes to other bacteria that are better adapted to 
aquatic environments (Börjesson, et al., 2009; Pote, et al., 2003; Schwartz, et al., 2003; 
Volkmann, et al., 2004). Additional studies exploring different tertiary treatments are 
necessary to determine what types of treatment can successfully reduce antibiotic-
resistant bacteria to non-detectable levels and what types of treatment can successfully 




No spray irrigation workers exposed to reclaimed wastewater in our study had 
nasal or dermal colonization of MRSA or VRE. Methicillin-susceptible S. aureus 
(MSSA) nasal colonization rates among the spray irrigation workers agreed with rates 
reported in the general population (31%), however 25% of the MSSA isolates were 
multidrug resistant. A higher percentage of MSSA nasal swab isolates were multidrug 
resistant from spray irrigation workers exposed to reclaimed wastewater compared to 
office worker controls (17%). To account for possible seasonal and regional variations, 
samples should be collected throughout the year and from multiple geographic regions. 
Public Health Implications 
A lack of epidemiological data limits the ability to determine the risk of infection 
from specific concentrations of microorganisms in environmental media (EPA, 1986a; 
Maier, 2009). Current national and state standards for water quality are based on studies 
conducted over twenty years ago and focused primarily on gastrointestinal illness 
outcomes (EPA, 1986a). However, the most commonly reported illnesses associated with 
water exposure are skin, throat, and upper respiratory tract (Charoenca & Fujioka, 1993; 
Favero, 1985; Hunter, Beach, Fleming, Teunis, & Wade, 2007; Maier, 2009). As recently 
as 2007, an expert scientific board suggested that EPA update its microbial water quality 
standards, but this has yet to take place (Hunter, et al., 2007). The findings from the 
current study will hopefully lay the foundation for future studies to determine the risk of 
infection from certain concentrations of MRSA, MSSA, VRE, and VSE isolated from 
wastewater and reclaimed wastewater irrigation samples. 
Federal water quality standards, including criteria for acceptable bacterial 




2009; Salzman & Thompson, 2007). Legal authority for controlling ambient water 
quality degradation rests with the states (Houck, 2002; Salzman & Thompson, 2007). For 
drinking water, the only bacterial concentrations contained in these regulations are for 
heterotrophic plate counts, coliforms, fecal coliforms, mycobacteria, and Legionella 
(EPA, 2009). However, it has been noted in numerous studies that enterococci are a 
better indicator of fecal contamination and have a stronger correlation with the 
occurrence of gastrointestinal illnesses than coliforms (EPA, 1986a; Favero, 1985; Maier, 
2009). Enterococci, along with E. coli, are currently used as water quality indicators for 
recreational water (EPA, 1986a). The current EPA guidelines for recreational water 
quality standards are 33 CFU/100 mL of enterococci in freshwater and 35 CFU/100 mL 
in marine waters (EPA, 1986a; Maier, 2009). The EPA standard is based on an 
acceptable risk of 8 gastrointestinal illnesses per 1000 swimmers in freshwater and 19 
gastrointestinal illnesses per 1000 swimmers in marine waters (EPA, 1986a). When 
freshwater is lightly or infrequently used for full body contact, the allowable CFUs/mL is 
even greater (107 and 151 CFU/mL) (EPA, 1986a). The concentration of enterococci 
isolated in the Inlet to Pumphouse samples at the spray irrigation in this study on August 
17 and October 27, 2009, were 128 and 320 CFU/100 mL respectively, one order of 
magnitude above EPA standards for enterococci in freshwater recreation waters with full 
body contact. The concentration of enterococci isolated in the Input to Pumphouse 
sample on August 17 was above the allowable levels for recreational water when lightly 
used for full body contact. The concentration of enterococci isolated in the October 27 
Input to Pumphouse sample was above the allowable levels for recreational water for 




recreational water quality standards by an expert scientific panel, concluded that the 
acceptable risk and the corresponding water quality standards had been set somewhat 
arbitrarily, do not take into account sensitive subpopulations, and might not be applicable 
to current water conditions and population characteristics (Hunter, et al., 2007). Based on 
these critiques and the results of the present study, the concentrations of Enterococcus 
spp. and VRE found in wastewater effluent and reclaimed wastewater samples might 
present a greater risk for gastrointestinal infection from exposure to reclaimed 
wastewater. 
Because skin, eye, ear, and upper respiratory infections are more common from 
contact with recreational water than gastrointestinal illnesses, it has been suggested that 
S. aureus might be a better indicator organism than coliforms, E. coli, or enterococci 
(Charoenca & Fujioka, 1993; Favero, 1985; Maier, 2009). Because the samples for S. 
aureus in the current study were enriched, we cannot determine the concentration of S. 
aureus in the wastewater samples and therefore cannot determine whether these levels 
could ultimately result in human infection. Also, the only infective dose for S. aureus 
that, to our knowledge, currently exists is for the enterotoxin produced by S. aureus that 
causes food poisoning. The infective dose of S. aureus toxin is reached when the number 
of organisms per milliliter (or gram) is greater than 100,000 (FDA, 2009). This dose 
roughly corresponds to 1 ug of toxin (FDA, 2009). There is no infective dose that has 
been calculated for the number of S. aureus that lead to other health outcomes, such as 





As water shortages occur more frequently and federal and state government 
agencies continue to encourage wastewater reuse, we can expect reclaimed wastewater 
reuse applications to continue to proliferate (MDE, 2009). The goal of this thesis was not 
to discourage the use of reclaimed wastewater, or to cause undue concern, but to evaluate 
the human health risks associated with its use, to be able to identify areas for 
improvement in terms of treatment and use, and to inform policy decisions in this area. 
Until we better understand the types of pathogens that remain in treated wastewater and 
the health risks from exposure to reclaimed wastewater, we cannot improve its use. 
Additional studies are necessary to determine if the patterns of multidrug resistant 
MSSA among spray irrigation workers identified in this study are statistically significant 
and relevant to other populations exposed to reclaimed wastewater. It is our hope that the 
results of this study encourage additional research and help inform decision makers about 















Source: EPA (2008). Clean Watersheds Needs Survey 2004. 







A. Reclaimed Wastewater Spray Irrigation Project Protocol  
 
Purpose: Presence/absence and enumeration experiments for presumptively 
identifying and archiving methicillin-susceptible, and -resistant Staphylococcus 
aureus (MRSA) and vancomycin-susceptible and -resistant Enterococcus spp. (VRE) 
from water, air, and nasal and dermal swab samples from wastewater treatment plant 
and spray irrigation sites. These experiments use MRSASelect chromogenic agar, 
Baird Parker agar (BP), Mannitol Salt Agar (MSA), Phosphate Buffered Saline 
(PBS), m Staphylococcus Broth, membrane-Enterococcus Indoxyl-β-D-Glucoside 
Agar (Yan, et al.), mEI amended with vancomycin, Enterococcosel Agar, and BHI 
agar. For more details on materials, please refer to Appendix A (page 15). 
 
 
Sampling Preparation (Week Before Sampling Scheduled) 
1. Calculate the amount of media needed for sample processing. 
 
2. Prepare vancomycin stock solution (*Unless stock solution is already in -80°C 
freezer). 
a. Measure about 12 mg vancomycin (Sigma Aldrich, St. Louis, MO) into 
weigh boat. 
b. Use the following equation to determine about of solvent/diluent needed: 
i. [(Y mg) x (X µg/ml)]/ (Z µg/ml) = W ml 
Where : Y = amount of antibiotic weighed on balance (do this first !) 
X = 1000 µg/ml = potency factor (*double check specific 
lot using MSDS sheet) 
Z = working stock desired concentration (usually 1000 
µg/ml) 
W = amount of solvent/diluent to dissolve antibiotic into 
c. Vortex. 
d. Store at 4°C if using in next few days, then freeze at -80°C. 
 
3. Prepare mEI agar amended with vancomycin 
a. Suspend 72 g of the mEI powder (EMD, Gibbsontown, NJ) in a 1 L of 
dH20. 





c. Autoclave at 121˚C for 30 minutes. 
d. Cool to 50 °C in water bath. 
e. Prepare a solution of 0.48g of Naladixic acid (Acros Organics, NJ, USA) 
in 10 ml of dH20. 
i. Add 0.4 mls of 10 N NaOH to dissolve.  
ii. Filter sterilize. 
iii. Add 5.2 ml solution to 1 L of mEI medium in hood. 
f. Prepare TTC. 
i. Add 0.1g of 2,3,5-triphenyltetrazolium chloride (TTC) (MP 
Biomedicals, Illkirch, Franch) to 10 ml dH20. 
ii. Warm to dissolve. 
iii. Filter sterilize 
iv. Add 2 mL TTC to 1 L mEI in hood and mix well. 
g. Prepare vancomycin solution. 
i. Use equation: c1v1 = c2v2 
Where c1 = concentration of antibiotic stock solution (usually 1000 
g/ml) 
 v1 = volume of antibiotic stock solution to add to agar 
 c2 = desired concentration in each plate = 16 µg/ml 
 v2 = volume of agar 
ii. Filter sterilize v1 of vancomycin stock solution. 
iii. Add to mEI in hood. 
h. Dispense 5-10 ml of agar into 15 × 60 mm plates and allow to solidify. 
i. Place in the refrigerator in lower “crisper” bin at 4°C for later use. 
 
4. Prepare MSA 
a. Suspend 111 g of the powder (Difco, Sparks, MD) in 1 L of ultrapure 
water. 
b. Heat with frequent agitation and boil for 1 minute to completely dissolve 
the powder. 
c. Autoclave at 121°C for 15 minutes. 
d. Pour into 15 x 150 mm Petri dishes. 
e. Place in the refrigerator at 4°C for later use. 
 
5. Prepare Enterococcosel Agar 
a. Suspend 56 g of powder (Difco, Sparks, MD) in 1 L of dH20. 
b. Mix thoroughly , heat and boil for 1 min to completely dissolve the 
powder. 
c. Autoclave at 121C for 30 min 
d. Cool to 50 °C 
e. Pour into 100 x 15mm Petri dishes and store. 
f. Place in the refrigerator at 4°C for later use. 
 
6.  Prepare m Staphylococcus Broth 





b. Warm slightly to completely dissolve the powder. 
c. Autoclave at 121°C for 15 minutes. 
d. Cool to 50 °C 
e. Place in the refrigerator at 4°C for later use. 
 
7. Prepare BHI Agar 
a. Suspend 52 g of powder (Difco, Sparks, MD) in 1 L of dH20. 
b. Mix thoroughly, heat and boil for 1 min to completely dissolve the 
powder. 
c. Autoclave at 121°C for 30 min 
d. Cool to 50 °C 
e. Pour into 15 x 150 mm Petri dishes. 
f. Place in the refrigerator at 4°C for later use. 
 
8. Prepare Phosphate Buffered Saline 
a. Dissolve 0.58g sodium dihydrogen phosphate, 2.5g sodium 
monohydrogen phosphate, and 8.5g sodium chloride in 1 L dH20. 
b. Autoclave at 121°C for 15 min 
c. Cool to 50 °C 
d. Final pH should be 7.4 ± 0.2. 
 
9. Prepare Water Membrane Filtration System 
a. Wash funnel system (Nalgene) 
b. Spray manifold with ethanol, turn upside down, and let dry on paper 
towels. 
c. Wrap funnel system in paper and autoclave using “Gravity” cycle. 
 
10. Prepare Tisch Impactor 
a. Wipe down impactor parts with 70% ethanol. 
b. Wrap top and inlets with aluminum foil. 
c. Autoclave on “Gravity” cycle to sterilize. 
d. Pack assembled impactor in pelican case. 
 
 
Day 1:  Sampling, Streak Nasal and Dermal Swabs 
 
1. Sampling: 
I. Nasal Samples 
a. Gently tilt participant’s head back and steady chin. 
b. Moisten cotton-tipped swab by swirling in Stuart’s transport media 
(Copan, Italy). 
c. Insert cotton-tipped swab approximately one-half inch into participant’s 
right nostril and gently rotate the swab five times over inside of nostril. 
d. Remove swab from participant’s nostril and immediately insert into 




e. Place cap on tube and label with unique coded identifier (Ex. SI1_03-
10_N001 to label a sample from spray irrigation site 1 taken in March 
2010 from participant 1’s nostril). 
f. Offer participant tissue to blow his nose. 
g. Use ethanol to clean hands between each subject. 
 
II. Dermal Samples 
a. Ask participant to pull up shirt sleeve of his right arm (if applicable). 
b. Moisten cotton-tipped swab in Stuart’s transport media (Copan, Italy). 
c. Gently swab a 2x2 inch area of participant’s forearm with cotton-tipped 
swab by rolling swab back and forth 15 times. 
d. Immediately insert the swab into Stuart’s transport media tube. 
e. Place cap on tube and label with unique coded identifier (Ex. SI1_03-
10_D001 to label a sample from spray irrigation site 1 taken in March 
2010 from participant 1’s forearm). 
f. Use ethanol to clean hands between each subject. 
 
III. Wastewater and Irrigation Water Samples 
a. Collect wastewater and irrigation water samples in 1-L and 500-mL 
Nalgene, polypropylene, wide-mouthed environmental sampling bottles. 
 
IV. Air Samples 
a. Warm-up portable generator for at least one-minute before connecting to 
the sampling train.  
b. Place pre-labeled TSA plates (ex. WW1_12-09_Effluent _stage1 10 min) 
in both stages of impactor. 
c. When ready to sample connect to the outlet of the generator and 
immediately record start time. 
d. Sample for the following times: 
1. All wastewater and spray irrigation samples: 1, 5, and 10 minutes 
2. Control: 1 and 5 minutes 
e. Turn off pump and remove TSA plates. 
f. Wipe down all parts of impactor after each sampling time with 70% 
ethanol. 
g. Re-start pump and sample for next time period. 
h. After sampling is complete, switch off pump. 
i. Place samples in cooler and transport to lab at 4°C. 
j. Incubate plates for 24 hours at 37°C. 
 
2. Nasal and Dermal Swabs 
1. Direct plating 
a. Label MSA and Baird Parker plates with date and unique coded identifier 
(Ex. SI1_08-09_N001). 
b. Streak MSA and Baird Parker plates each with one side of cotton-tipped 




c. Streak a (+) S. aureus control and (-) control plate on both MSA and Baird 
Parker and incubate overnight at 37°C. 
d. Label EA plates with date and unique coded identifier. 
e. Streak EA plate with second side of cotton-tipped swab. Incubate 
overnight at 41°C.  
f. Streak a (+) Enterococcus spp. control and (-) control plate and incubate 
overnight at 41°C. 
 
 
Day 2: Water Membrane Filtration, Air Sample Plate Replication, Nasal and 
Dermal Swab Subculturing 
 
1. Water Membrane Filtration (IMPORTANT: Must be within 24 hours of sample 
collection) 
a. Label all plates with the appropriate sample media code and dilution 
(Example: WW1_10-09_1° influent_10 mls). 
b. Aseptically assemble the vacuum manifold/flask system, making sure that a 
trap is placed between the flask and the pump vacuum line to protect the 
vacuum line from contamination.  










d. Using aseptic technique, prepare serial dilutions of your sample, taking into 
consideration any rain events that may have occurred before sample. 
i. Dilutions for Influent Wastewater and Activated Sludge Reactor 
Samples: 1, 0.1, 0.01, 0.001 mls.   
ii. Secondary Clarifier dilutions: 100, 10, 1 mls 
iii. Effluent: 1 L (or as much close to 1 L as possible, record exact volume 
filtered) 
iv. Spray Irrigation Samples: 
1. Before UV, After UV, and Input to Pond: 1 L (if possible), 300 
mls, 100 mls 
2. Inlet to Pumphouse: 200,100, and 10 mls 
e. Using sterilized tweezers, place a Millipore mixed cellulose filter (Millipore 
Corp., Billerica, MA) on the filter funnel, grid side up. 
f. Secure funnel and starting with the lowest dilution, pipette 10mls of sample 
dilution into funnel, filter, and follow with 10mls PBS to rinse. 
Vacuum manifold 
 








g. Turn off suction, carefully remove filter with tweezers and place on 60x15mm 
mEI plate. Double bag in whirlpack bags and incubate at 41.5°C for 24-48 
hours in water bath. 
h. Place a new cellulose filter on funnel, secure funnel and pipette same dilution, 
this time placing on 60x15mm mEI+van plate. Double bag in whirlpack bags 
and incubate at 41.5°C for 24-48 hours in water bath. 
i. Place a new cellulose filter on funnel, secure funnel and pipette your next 
dilution. 
j. Place filters on mEI and mEI+van plates. 
k. After 3 samples, soak filter funnels with 70% ethanol, let air dry, and apply 
UV light under hood for 5-10 minutes. 
l. Set up a positive (+) and negative (-) control plates. 
i. For positive control, suspend known Enterococcus colony in PBS. 
ii. For negative control, filter 10 mls of PBS. 
m. For S. aureus and MRSA enrichment: 
i. Label 50 ml Falcon tube with sample location, date, and initials 
(Example: WW1_10-09_ASR_mStaphB).  
ii. Filter 300 mls of influent wastewater (use more than one filter if 
necessary). 
iii. Add filter(s) to 40 mls of m Staph Broth in 50 ml Falcon tube. 
iv. Vortex 
v. Incubate at 37°C for 24 hours. 
 
2. Air Samples – Plate Replication 
1. Take TSA plates out of incubator and record presence/absence of growth. 
If there is no growth, leave in incubator for an additional 24 hours. 
2. For TSA plates with growth, use wooden replicator. 
3. Cover wooden replicator with velvet pads. 
4. Label plates with sample name and time, initials, and date. 
5. Press velvet pad covered replicator into Baird Parker, MSA, Chapman 
Stone, mEI, mEI +vancomycin, and TSA plates lined up in a row. 
6. Press firmly enough to pick up all colonies, but not so hard that plate 
moves or colonies are squashed. Feel “jiggle.” 
7. Incubate overnight at 37°C. 
 
3. Nasal and Dermal Swabs: Subculturing 
Target colony (EA): Colonies with black precipitate; Take up to 10 target organisms 
from each sample and subculture onto vancomycin-amended EA to determine if they 
are vancomycin-resistant Enterococcus spp. 
1. Label plates with Initials, Date, and sample ID (Example: WW1_10-09_N001). 
2. With a marker, divide each plate into three sections. 
3. Select 10 target colonies and streak each colony onto a section of the EA+van 
plate. 
4. Incubate overnight at 41°C. 
 





- MSA: Yellow colonies with yellow precipitate 
- BP: Black shiny colonies with clear halo 
 
1. Label plates with Initials, Date, and sample ID (Example: WW1_10-
09_N001). 
2. With a marker, divide each plate into three sections. 
3. Take up to 10 target organisms from each sample. 
4. Streak for isolation onto a TSA plate. 
5. Incubate for 24 hours at 37°C. 
 
 
Day 3: Isolation from Water Samples, Prepare Air Samples for Biochemical Testing, 
Biochemical Testing on Nasal and Dermal Swabs 
 
1. S. aureus from Water Samples 
1. Label 2 MSA and Baird Parker plates for each sample with Initials, Date, and 
sample ID (Example: WW1_10-09_Inf1). 
2. Take m Staph B out of incubator. 
3. Using calibrated10 µl loop, streak 10 µl of m Staph B onto 2 MSA and Baird 
Parker plates.  
4. Incubate at 37°C for 24 hours. 
 
2. MRSA from Water Samples 
1. With marker, divide each MRSASelect plate in half. 
2. Label  MRSASelect plates with Initials, Date, and sample ID (Example: 
WW1_10-09_Inf1). 
3. Take m Staph B out of incubator. 
4. Using calibrated 10 µl loop, streak 10 µl of m Staph B onto both halves of a 
MRSASelect plate.  
5. Incubate at 37°C for 24 hours. 
 
3. Water Samples - Enterococcus - Colony Count 
1. Obtain your mEI plate from the incubator. 
2. Use counter pen in Prep Lab for colony count. 
3. Record colony forming units for each plate. 
 
4. Water Samples - Enterococcus – Prepare for Biochemical Tests 
Target Colonies: 
mEI: Colonies with blue halo (regardless of colony color) 
mEI+van: Colonies with blue halo (regardless of colony color) 
 
1. Label your BHI plate with Initials, Date, and sample ID (Example: WW1_10-
09_Inf1). 




3. Select up to 10 target colonies from each sample (you do not need to take 10 
colonies from each dilution, only 10 total for each sample location). 
4. Streak for purification on BHI agar. 
5. Incubate at 41°C for 24 hours. 
6. Streak positive and negative control plates and incubate overnight at 41°C. 
 
5. Air Samples – Prepare presumptive isolates for Biochemical Tests 
Target colonies: 
1. MRSASelect: Pink colonies 
2. MSA: Yellow colonies with yellow precipitate 
3. BP: Black shiny colonies with clear halo 
4. mEI: Colonies with blue halo (regardless of colony color) 
5. mEI+van: Colonies with blue halo (regardless of colony color) 
 
1. For Presumptive Enterococcus spp. and VRE: 
i. Label your BHI plate with Initials, Date, and sample ID (Example: 
WW1_10-09_Inf1). 
ii. With a marker, divide each plate into three sections. 
iii. Select up to 10 target colonies from each sample (you do not need to 
take 10 colonies from each dilution, only 10 total for each sample 
location). 
iv. Streak for purification on BHI agar. 
v. Incubate at 41°C for 24 hours. 
vi. Streak positive and negative control plates and incubate overnight at 
41°C. 
2. For Presumptive S.aureus and MRSA: 
Target colonies: 
-CSA: white colonies with clear halo. 
-MSA: Yellow colonies with yellow precipitate 
-BP: Black shiny colonies with clear halo 
 
i. Label your TSA plate with Initials, Date, and sample ID (Example: 
WW1_10-09_Inf1). 
ii. With a marker, divide each plate into three sections. 
iii. Select 10 target colonies and streak each colony onto a section of the 
TSA plate for purification.  
iv. Incubate for 24 hours at 37°C. 
v. Streak positive and negative control plates and incubate overnight at 
37°C. 
 
6. Biochemical Tests - Nasal and Dermal Swabs - Presumptive S. aureus and MRSA  
Using Gram Stain, catalase test, and coagulase test, you will be able to 






• The Gram stain will confirm that you have a pure culture and it will also confirm 
that you have a Gram-positive coccus (morphology and gram reaction for S. 
aureus).   
• The catalase test examines the ability to breakdown hydrogen peroxide by 
catalase. Those organisms possessing the catalase enzyme will break down 
hydrogen peroxide into water and oxygen.  The oxygen causes bubbles to form 
within, seconds, indicating a positive test.  The absence of bubbles is considered 
a negative test.  S. aureus is catalase positive.  
• The Coagulase Plasma, Rabbit with EDTA (Difco, Sparks, MD) detects coagulase 
(both bound and free) to identify S. aureus and separate it from other species of 
staphylococci. Any degree of clotting is considered positive.  
 
Obtain your TSA plates from the incubator and record results. Make sure that you 
have a pure (and NOT mixed) culture. 
 
I. Gram Stain 
a. Prepare smear. 
b. Perform Gram Stain as directed. 
c. Record observations. 
 
II. Catalase Test 
a. Collect an empty Petri dish and place one drop of 3 % hydrogen 
peroxide/per sample on to surface of Petri dish. 
b. Take small swab from each sample and place into the 3 % hydrogen 
peroxide. 
c. Examine plates for bubbles.  Presence of bubbles= positive result; 
Absence of bubbles =negative result. 
d. Record observations. 
 
III. Coagulase Test 
a. Take out coagulase test from refrigerator. 
b. Rehydrate plasma by adding 3 ml of sterile dionized water to bottle. 
c. Mix by rotating end over end. 
d. Add 300 µl rehydrated plasma to a glass tube. 
e. Add 4-5 colonies of presumptive S.aureus from a non-selective agar plate. 
f. Vortex. 
g. Incubate at 37°C for up to four hours. 
h. Check tubes every hour for up to four hours, and then again after 24 hours. 
i. Partial or complete coagulation=positive result. No coagulation=negative 
result. 
j. Record observations. 
 
** For isolates with positive gram stain (+), catalase (+), and Coagulase tests (+), 
store in 4°C refrigerator until purification on Day 5 and archiving on Day 6. 





Day 4: Prepare Water Samples for Biochemical Testing, Biochemical Testing on Air 
Samples and Enterococcus from Water Samples 
 
1. S. aureus and MRSA from Water: Prepare for Biochemical Testing 
Target colonies: 
-MRSASelect: Hot pink colonies 
-MSA: Yellow colonies with yellow precipitate 
-BP: Black shiny colonies with clear halo 
 
a. Label your TSA plate (Initials, Date, presumptive organism, source, 
etc.). 
b. With a marker, divide each plate into three sections. 
c. Select 10 target colonies and streak each colony onto a section of the 
TSA plate for purification.  
d. Incubate for 24 hours at 37°C. 
e. Streak positive and negative control plates and incubate overnight at 
37°C. 
 
2. Water and Air Samples – Biochemical Tests - Enterococcus spp. and VRE 
Using Gram Stain, catalase test, and PYR test, you will be able to presumptively 
identify Enterococcus from your positive water samples. 
 
• The Gram stain will confirm that you have a pure culture and it will also confirm 
that you have a Gram positive coccus (morphology and gram reaction for 
Enterococcus).   
• The PYR test (Remel, Lenexa, KS) is a rapid, colorimetric test recommended for 
use in qualitative procedures for the detection of pyrrolidonyl arylamidase 
activity for presumptive identification of enterococcoci, group A streptococcoci, 
and Escherichia coli. 
• The catalase test examines the ability to breakdown hydrogen peroxide by 
catalase. Those organisms possessing the catalase enzyme will break down 
hydrogen peroxide into water and oxygen.  The oxygen causes bubbles to form 
within, seconds, indicating a positive test.  The absence of bubbles is considered 
a negative test.  Enterococcus is catalase negative (or very weakly positive).  
 
Obtain your BHI purification plates from the incubator and record results. Make sure 
that you have a pure (and NOT mixed) culture. 
 
IV. Gram Stain 
a. Prepare smear. 
b. Perform Gram Stain as directed. 
c. Record observations. 
 
V. PYR Test  
a. Test isolates should be 18-24 hours old and taken from non-selective 




b. Using forceps, place the disk on a clean microscope slide or in the lid of a 
Petri dish free from excess moisture.   
c. Moisten the disk slightly with 5-10 ul of demineralized water using a 
micropipette or a 10 uL inoculating loop.  DO NOT OVERSATURATE. 
d. Remove a visible “paste” of the test isolate using a sterile loop. 
e. Rub the inoculums gently into a small area of the disk. 
f. Add one (1) drop of PYR Reagent to the disk. 
g. Allow up to one minute for a color change. 
i. Positive test= pink to red color development w/in 1 min of 
applying PYR reagent 
ii. Negative test= Cream, yellow, or no color change within one 
minute of applying PYR Reagent 
 
VI. Catalase Test 
a. Collect an empty Petri dish and place one drop of 3 % hydrogen 
peroxide/per sample on to surface of Petri dish. 
b. Take small swab from each sample and place into the 3 % hydrogen 
peroxide. 
c. Examine plates for bubbles.  Presence of bubbles= positive result; 
Absence of bubbles =negative result. 
d. Record observations. 
 
** For isolates with positive gram stain (+), negative catalase (-), and positive PYR 
tests(+), set aside for purification on Day 5 and archiving on Day 6. These isolates can be 
presumptively identified as Enterococcus spp. and VRE. 
 
 
3. Air Samples – Biochemical Tests – S. aureus and MRSA 
Using Gram Stain, catalase test, and coagulase test, you will be able to 
presumptively identify S. aureus and MRSA from your positive nasal and dermal 
swab samples. 
  
• The Gram stain will confirm that you have a pure culture and it will also confirm 
that you have a Gram-positive coccus (morphology and gram reaction for S. 
aureus).   
• The catalase test examines the ability to breakdown hydrogen peroxide by 
catalase. Those organisms possessing the catalase enzyme will break down 
hydrogen peroxide into water and oxygen.  The oxygen causes bubbles to form 
within, seconds, indicating a positive test.  The absence of bubbles is considered 
a negative test.  S. aureus is catalase positive.  
• The Coagulase Plasma, Rabbit with EDTA (Difco, Sparks, MD) detects coagulase 
(both bound and free) to identify S. aureus and separate it from other species of 
staphylococci. Any degree of clotting is considered positive.  
 
Obtain your TSA plates from the incubator and record results. Make sure that you 





I. Gram Stain 
a. Prepare smear. 
b. Perform Gram Stain as directed. 
c. Record observations. 
 
II. Catalase Test 
a. Collect an empty Petri dish and place one drop of 3 % hydrogen 
peroxide/per sample on to surface of Petri dish. 
b. Take small swab from each sample and place into the 3 % hydrogen 
peroxide. 
c. Examine plates for bubbles.  Presence of bubbles= positive result; 
Absence of bubbles =negative result. 
d. Record observations. 
 
III. Coagulase Test 
a. Take out coagulase test from refrigerator. 
b. Rehydrate plasma by adding 3 ml of sterile dionized water to bottle. 
c. Mix by rotating end over end. 
d. Add 300 µl rehydrated plasma to a glass tube. 
e. Add 4-5 colonies of presumptive S.aureus from a non-selective agar plate. 
f. Vortex. 
g. Incubate at 37°C for up to four hours. 
h. Check tubes every hour for up to four hours, and then again after 24 hours. 
i. Partial or complete coagulation=positive result. No coagulation=negative 
result. 
j. Record observations. 
 
** For isolates with positive gram stain (+), catalase (+), and Coagulase tests (+), 
store in 4°C refrigerator until purification on Day 5 and archiving on Day 6. 
These isolates can be presumptively identified as S. aureus or MRSA. 
 
 
Day 5: Biochemical Testing of S. aureus and MRSA from Water Samples, 
Purification for All Samples 
 
1. Water Samples – Biochemical Tests - Presumptive S. aureus and MRSA  
Using Gram Stain, catalase test, and coagulase test, you will be able to 
presumptively identify S. aureus and MRSA from your positive samples. 
  
• The Gram stain will confirm that you have a pure culture and it will also confirm 
that you have a Gram-positive coccus (morphology and gram reaction for S. 
aureus).   
• The catalase test examines the ability to breakdown hydrogen peroxide by 
catalase. Those organisms possessing the catalase enzyme will break down 




within, seconds, indicating a positive test.  The absence of bubbles is considered 
a negative test.  S. aureus is catalase positive.  
• The Coagulase Plasma, Rabbit with EDTA (Difco, Sparks, MD) detects coagulase 
(both bound and free) to identify S. aureus and separate it from other species of 
staphylococci. Any degree of clotting is considered positive.  
 
Obtain your TSA purification plates from the incubator and record results. Make sure 
that you have a pure (and NOT mixed) culture. 
 
I. Gram Stain 
a. Prepare smear. 
b. Perform Gram Stain as directed. 
c. Record observations. 
 
II. Catalase Test 
a. Collect an empty Petri dish and place one drop of 3 % hydrogen 
peroxide/per sample on to surface of Petri dish. 
b. Take small swab from each sample and place into the 3 % hydrogen 
peroxide. 
c. Examine plates for bubbles.  Presence of bubbles= positive result; 
Absence of bubbles =negative result. 
d. Record observations. 
 
III. Coagulase Test 
a. Take out coagulase test from refrigerator. 
b. Rehydrate plasma by adding 3 ml of sterile dionized water to bottle. 
c. Mix by rotating end over end. 
d. Add 300 µl rehydrated plasma to a glass tube. 
e. Add 4-5 colonies of presumptive S.aureus from a non-selective agar 
plate. 
f. Vortex. 
g. Incubate at 37°C for up to four hours. 
h. Check tubes every hour for up to four hours, and then again after 24 
hours. 
i. Partial or complete coagulation=positive result. No 
coagulation=negative result. 
j. Record observations. 
 
 
IMPORTANT:  From presumptive MRSA: if you have pink colonies, (+) gram stain, 
(+) coagulase test, and (+) catalase test, then purify the isolate as follows: 
 
2. Purification – From All Sample Types (Nasal, Dermal, Air, and Water) 






*Presumptive MRSA and S. aureus: positive gram stain, catalase, and Coagulase 
tests. 
 
*Presumptive VRE and Enterococcus spp.: positive gram stain, negative catalase, 
and positive PYR tests. 
 
a. Label your BHI plate (Initials, Date, presumptive organism, source, etc.). 
b. With a marker, divide each plate into three sections. 
c. Select 10 target colonies and streak each colony onto a section of the BHI 
plate for purification. Incubate overnight at 37°C (presumptive MRSA and S. 
aureus) or 41°C (presumptive VRE and Enterococcus spp). 




Day 6:  Archiving of Sample Isolates 
 
Obtain your BHI purification plates from the incubator.  Also gather Brucella Broth 
and glycerol. 
 
1. Prepare 15% glycerol and Brucella Broth solution. 
2. Observe and record the results of your BHI plate.  Compare your plate to the 
control plate and make sure that you have a pure (and NOT mixed) culture.  
3. Add 1 mL of 15% glycerol and Brucella Broth to a 1.5 mL cryogenic tube.  
4. Label your 15% glycerol with Brucella Broth tube using the labeling machine 
with the following information: Date Archived, Sample Location, Date of 
sampling, Type of organism, Isolate number (Example: 12-08-09; WW1_12-
09_MRSA1).  
5. Record labeling scheme in lab notebook. 
6. Using a sterile loop, collect one single colony from BHI plate.  Place into the 
Brucella Broth and gently swirl in order to get remainder off of loop. 
7. Vortex. 
8. Place isolates in the -80°C freezer in box clearly labeled with sampling date, type 
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B. Participant Questionnaire 
SPRAY IRRIGATION WORKER STUDY 
1.1)  Interviewer Name   
1.2)  Date of Interview   
1.3)  Subject ID Number |__|__|__|__| 
1.4)  Gender (Circle one) (1) Male                                                             (2) Female 
1.5)  Age   |__|__| 
1.6)  Race (Circle one) 
(1) Caucasian                                                   
(2) Black                                                                    
(3) Hispanic                                                
(4) Asian                                                       
(5) Other  
1.7)  Education (Circle one) 
(1) Less than high school                                 
(2) High School                                             
(3) Associate                                        
(4) College  
1.8)  Occupation (Circle one): (1) Irrigation Worker                                (2) Office Worker 
1.9)  How long have you had this job?   |__|__| Years 
1.10)  How many days a week do you spend in 
this job?   |__|__| Days 
1.11)  How many hours a day do spend in                               
this job?   |__|__| Hours 
1.12)  Do you wear personal protective 
equipment when spraying water at this job? 





1.13)  Yearly Income (Circle one) 
(1) Less than $15,000                                 
(2) $15,000-$25,000                                             
(3) $25,000-$35,000                                    
(4) $35,000-$50,000                               
(5) >$50,000  
1.14)  Have you ever worked in a healthcare 
setting? 
(1) Yes                                                                            
(2) No 
1.15)  Has anyone in your household ever 
worked in a healthcare setting? 
(1) Yes                                                                            
(2) No 
1.16)  Have you had a nosebleed within the last 
three days? 
(1) Yes                                                                            
(2) No 
1.17)  Have you ever been diagnosed with 
methicillin-resistant Staphylococcus aureus 
(MRSA)? 
(1) Yes                                                                            
(2) No                                                           
(3) I don't know 
1.18)  Have you smoked at least 100 cigarettes 
in the past 6 months? 
(1) Yes                                                                            
(2) No 
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